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Abstract 
Flexible Microimplants for In Vivo Sensing 
Thesis by 
Yu Zhao 
Doctor of Philosophy in Electrical Engineering 
California Institute of Technology 
 
The work in this thesis develops two types of microimplants for the application of 
cardiovascular in vivo biomedical sensing, one for short-term diagnosis and the other for 
long-term monitoring.  
Despite advances in diagnosis and therapy, atherosclerotic cardiovascular disease 
remains the leading cause of morbidity and mortality in the Western world. Predicting 
metabolically active atherosclerotic plaques has remained an unmet clinical need. A 
stretchable impedance sensor manifested as a pair of quasi-concentric microelectrodes 
was developed to detect unstable intravascular. By integrating the impedance sensor with 
a cardiac catheter, high-resolution Electrochemical Impedance Spectroscopy (EIS) 
measurements can be conducted during cardiac catheterization. An inflatable silicone 
balloon is added to the sensor to secure a well-controlled contact with the plaque under 
test in vivo. By deploying the device to the explants of NZW rabbit aorta and live animals, 
distinct EIS measurements were observed for unstable atherosclerotic plaques that 
harbored active lipids and inflammatory cells.  
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On the other hand, zebrafish (Danio rerio) is an emerging genetic model for heart 
regenerative medicine. In humans, myocardial infarction results in the irreversible loss of 
cardiomyocytes. Zebrafish hearts can fully regenerate after two months with 20% 
ventricular resection. Long-term electrocardiogram (ECG) recording during heart 
regeneration can characterize whether the structurally regenerated cardiomyocytes can 
display functionally normal conduction phenotype.  A flexible microelectrode membrane 
was developed to be percutaneously implanted onto a zebrafish heart and record 
epicardial ECG signals from specific regions on it. Region-specific aberrant cardiac 
signals were obtained from injured and regenerated hearts.  Following that, in order to 
achieve continuous and wireless recording from non-sedated and non-restricted small 
animal models, a wireless ECG recording system was designed for the microelectrode 
membrane, prototyped on a printed circuit board and demonstrated on a one-day-old 
neonatal mouse. Furthermore, a flexible and compact parylene C printed circuit 
membrane was used as the integration platform for the wireless ECG recording 
electronics. A substantially miniature wireless ECG recording system was achieved.  
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Chapter 1 : Introduction 
Bian Que was the most recognized physician in ancient China. He was once asked 
by a King, “The three brothers in your family are all skilled in medicine. Which one of 
you is the best? Bian Que modestly told the King that his eldest brother was the best, then 
his second brother, and he was the third. He further explained: My eldest brother gives 
medical treatment to patients before the onset of a disease. The patients would not even 
realize they were sick. So it is difficult for them to recognize his medical skills. Only my 
family members are able to appreciate him. As for my second brother, he treats a disease 
at its early stage when the symptoms are not very obvious. Thus, people tend to believe 
he is only capable of treating minor sickness. As for me, I treat a disease when it is 
already well developed. People are seriously ill. They watch me inject needles, let blood, 
apply poison drugs on wounds, do surgery…These things help patients by relieving pain 
and illness and make me well-known all over the country.   
The wisdom behind this story is the significance of long-term monitoring, early 
detection and accurate diagnosis, which can be essentially achieved by in vivo sensing in 
the practice of modern medicine.  
1.1 In Vivo Sensing 
1.1.1 Significance of In Vivo Sensing 
In vivo sensing can be referred to specifically as detecting and quantifying 
medically useful variables to assess body function [1]. In vivo sensors are developed to 
directly interrogate biological processes in living organisms. In contrast, in vitro sensors 
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are not able to continuously monitor biological events in situ and often fail to capture the 
complexity of intact organ systems  [2]. Driven by the advancements of both biology and 
technologies, emerging in vivo sensors have begun to be applied in living systems to 
dynamically and continuously monitor biological processes. These in vivo sensors have 
great potentials in continuous, rapid monitoring of biological systems in the context of 
diseases, informing response to therapies, accelerating detection of diseases, and 
understanding of normal biology [3].  
1.1.2 Challenges of In Vivo Sensing 
The challenges of in vivo sensing lie in both the inaccessibility of in vivo tissues 
and fundamental difficulties in sensor design and application [2].  Normally, an in vivo 
sensor is simply composed of a detector (such as an electrode, antibody, aptamer, peptide 
or enzyme) paired with a detection method (which may be electrochemical, optical or 
magnetic, among others) [4-7]. Accordingly, sensing in vivo requires both the detector 
and detection method biocompatible, nontoxic, not perturbing the system being examined, 
capable of monitoring signals within a living system with necessary sensitivity and 
specificity [1, 3, 4].  
The time scale of in vivo sensing could vary from hours or days to years, thus 
imposing different challenges and constraints on the hardware implementation [8, 9].  In 
this dissertation, in vivo sensing is generally classified into short-term in vivo sensing and 
long-term in vivo sensing. In both scenarios, minimal perturbation of normal biology is of 
utmost importance while developing in vivo sensors [2]. This includes minimizing the 
scar tissue formation and immunogenicity during implantation and around implantation 
sites.  
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1.1.3 Short-Term In Vivo Sensing 
Short-term in vivo sensing commonly aims to accurately diagnose a disease in its 
early stage. It has been found to integrate well with available minimally invasive 
diagnosis and treatment such as cardiac catheterization [10].  
 
 
Figure 1.1. An illustration of cardiac catheterization.  A: Right-sided heart catheterization. 
The catheter is inserted into the femoral vein and advanced through the inferior vena cava 
(or, if into an antecubital or basilic vein, through the superior vena cava), right atrium, 
right ventricle and into the pulmonary artery. B: Left-sided heart catheterization. The 
catheter is inserted into the femoral artery or the antecubital artery. The catheter is passed 
through the ascending aorta, through the aortic valve, and into the left ventricle.  
(From Ignatavicius and Workman, 2002) 
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Cardiac catheterization enables doctors to access diseased sites that need to be 
monitored and treated via the circulatory system [11]. Specialized tubes or catheters are 
threaded up through the blood vessels in the groin, arm, or neck to an area of the body 
that needs diagnosis and treatment (Fig. 1.1). The problem is then checked from the 
inside of the blood vessel. Depending on the blood vessel sizes, the catheters are 
approximately 0.3-3.0 mm in diameter and 1.5 m in length [11]. The merits of this 
approach include that catheterization does not require surgical incisions at the monitoring 
site, hospital stays are usually one night or less, and the discomfort and recovery times 
afterward are minimal. Therefore, cardiac catheterization is considered a minimally-
invasive procedure. 
During cardiac catheterization, short-term in vivo sensing can gather additional 
information for diagnosis, monitoring during operation and checking results after 
procedures [10]. 
MEMS pressure sensors are now commonly found on cardiac catheter devices 
[12]. For example, Millar’s Mikro-TipR ultra-miniature pressure-volume catheters are 
coupled with an ultra-miniature pressure sensor with an outer diameter of 330 m to 670 
m (Fig. 1.2). They are capable of measuring both left ventricular pressure and volume 
simultaneously from the intact, beating hearts of mice and rats. Many other types of 
MEMS sensors are being researched for placement on diagnostic catheters to measure 
blood flow, pressure, temperature, oxygen content, and chemical concentration [11, 13-
15].   
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Figure 1.2. Ultra-miniature pressure sensor on catheter tip from Millar’s Mikro-TipR. 
1.1.4 Long-Term In Vivo Sensing 
Long-term in vivo sensing can be a key component of an ideal monitoring system 
for early detection or a close-loop treatment for uncured disease. Two examples are 
discussed here.  
The first example is the early detection of glaucoma, which highlights the 
significance of a high-accuracy monitoring system. Glaucoma is the leading cause of 
blindness in the world, according to the World Health Organization [16]. The majority of 
glaucoma patients have an intraocular pressure (IOP) larger than 20 mmHg (compared 
with a normal IOP of ~10 mmHg), which could damage the patients’ optic nerve in the 
backside of the eye and causes irreversible blindness. Currently, there is no cure for 
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glaucoma, but the visual loss can be slowed or eliminated with early diagnosis and proper 
treatment to lower the high intraocular pressure. Thus, long-term implantable sensors that 
can continuously monitor intraocular pressure have been widely developed for an early 
detection and treatment [17, 18].  
The second example is the implantable glucose sensor. Currently, the finger-prick 
sampling method of glucose monitoring is predominantly used in diabetes management. 
Nevertheless, there has always been a strong push for continuous glucose monitoring, 
which could form a close-loop control system and make real-time and optimal insulin 
delivery [19]. With a well-regulated blood glucose level, the short-term crises and long-
term complications associated with diabetes could be minimized [9, 19]. A wide range of 
in-vivo glucose electrochemical sensors, presenting different needle designs, materials 
and membrane coatings, has been studied in both industry and research [20-22].  
1.2 Microimplants for In Vivo Sensing 
1.2.1 Introduction to Microimplants 
The scale of microimplants in this dissertation has two folds. First, devices that are 
intended to function inside the body for some period (short-term or long-term) and 
secondly, devices that have at least one part made using integrated circuit-like fabrication 
technology with micron-sized features.  
Microimplants have been found in a myriad of monitoring, diagnostic, therapeutic, 
and interventional applications. Well-known examples include cardiac pacemakers [23] 
and defibrillators [24]. There are also emerging applications such as the visual prosthesis 
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devices [25] and the embedded monitoring devices targeting a variety of physiological 
variables including oxygen, glucose, pH level, pressure, and temperature [9, 26, 27]. 
1.2.2 Hardware Implementation of Microimplants 
For the application of in vivo sensing, the hardware implementation of 
microimplants usually shares a common set of four function modules including signal 
sensing, signal processing, data transmission and power transmission [1, 11]. 
Physiological signals are obtained by front-end sensors, processed and transmitted 
through a wired or wireless communication scheme to the exterior monitoring/diagnosing 
unit. Signals need to be transmitted through every medium in between the implant and 
the external unit. A wireless data transmission could be achieved by modulating different 
energy forms, such as electromagnetic waves, light and ultrasound [28, 29]. Power can be 
provided by wired connection, implantable battery, wireless energy transmission or 
energy harvesting.  
1.2.3 Challenges of Microimplant Development 
The requirements of microimplants are application specific, but there are several 
challenges commonly encountered in module implementation. Three of the major 
challenges as well as the previous research efforts conducted to tackle the challenges are 
reviewed in this section.  
1.2.3.1 Sensor 
For in vivo sensing, either long-term or short-term, one major challenge is how to 
make it minimally invasive. The sensor should be of a very tiny size and proper shape 
that minimizes surgical damage during implantation and reduces discomfort after 
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implantation. The front-end signal-sensing module forms the interface between the 
biological tissue and the engineering device. Careful consideration is given to the 
mechanical properties of the biological tissue, the anatomical structure of the 
implantation site, the relative mechanical movement between the implant and the 
surrounding tissue, when selecting implant materials and determining the mechanical 
design of the implant. For one example, the chemical composition of the implant should 
not increase or extend the presence of the implant [30]. For another example, sharp edges 
and corners should be avoided [31]. Furthermore, biocompatible coatings could be 
important to further minimize the body’s immune response. Meanwhile, the surgical 
procedure performed to implant a device may also cause a series of foreign body 
reactions. Therefore, the device should have an optimal design to minimize surgical 
damage during implantation [32].  
1.2.3.2 Power 
For short-term in vivo sensing, it is practical to make wired connections to supply 
power to the sensor. For long-term in vivo sensing, wired powering connections can 
restrict the movement and increase the chances of infection. Using an implantable battery is 
an option, but the increased total size of the device limits the choice of implantation sites. 
Also, battery lifetime is usually limited, and even rechargeable batteries have a limited 
number of recharging cycles. Energy harvesting could be used in implants, but the amount 
of power collected from the body is usually too low for practical use.  
Inductive coupling through a pair of coils appears to be one of the most promising 
approaches in wireless power transfer. In this scheme, one coil is placed outside of the 
implantation site and another one is implanted inside to form a loosely-coupled transformer. 
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The medium between the coils could include air, water, and biological tissue (Fig. 1.3). To 
obtain a higher power coupling efficiency, an external capacitor is added to form a tuned-
in-series external resonator and a turned-in-parallel implanted resonator with the pair of 
coils, respectively. When the transmitter coil is driven by the sinusoidal signals at the 
resonating frequency, it creates a changing electromagnetic field. The implanted coil 
captures a portion of it and has current produced in the resonator. Considering the tissue 
absorption rate and power transfer efficiency, the operational frequency, which is the 
resonating frequency at the same time, should be in the range of 1 and 20 MHz and the 
power transmitted from the external unit should not exceed 10 mW/cm2 in compliance with 
government safety standards. 
 
Figure 1.3. Inductive coupling circuit schematic circuit. 
1.2.3.3 Integration 
To build a complete implantable system that includes the function modules of 
sensing, processing, data transmission and power transmission, it is of great importance 
to use a flexible and miniaturized integration with small footprints, high functionality, 
high reliability and biocompatibility [33].  
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Application-specific integrated circuits (ASICs) can achieve high integration 
density of the electronic circuitry including single transmission, power management as 
well as signal processing. However, the major challenge lies in the hybrid integration of 
the whole system and how to further minimize it [33]. On the other hand, a flexible 
substrate is preferred considering the implantable systems could be in direct contact with 
delicate and soft tissue and biological structures.   
For small volume production at the proof of concept stage, flip-chip bonding and 
a modified stud ball technique (“MicroFlex Technique”) have been developed for  
integration of standard integrated circuits (ICs) and discrete components onto the flexible 
interconnecting polyimide substrate [34] (Fig. 1.4).  
 
Figure 1.4. Modified stud ball technique used in “MicroFlex”. 
1.3 Parylene-based Flexible BioMEMS 
1.3.1 Introduction to BioMEMS 
Microelectromechanical systems (MEMS) technologies generally refer to the 
processes of fabrication of miniaturized structures of micrometer scales. They originated 
                                                         11 
from the microfabrication processes used for integrated circuit fabrication and 
semiconductor manufacturing, then were later adapted and extended to include some 
other similar techniques. The major concepts and principles behind MEMS technologies 
are photolithography, thin films deposition and etching techniques. By repeating the 
sequences of deposition, photolithography patterning and etching, desired features can be 
produced in a layer-by-layer fashion.  
BioMEMS is a sub-domain of MEMS and its emergency has given rise to a lot of 
interdisciplinary research in biomedical applications. A lot of bioMEMS devices for in 
vitro diagnostic use have been fabricated and tested in the laboratory stage, such as micro 
channels, micro valves, micro cantilevers, micro pumps and micro reservoirs [35-37]. 
There has long been interest in applying bioMEMS technologies for in vivo sensing 
because bioMEMS technologies offer great potential in making devices and components 
with small and well-controlled features, high reproducibility and uniformity, low weight 
and cost, superior functionality and performance [38]. In addition, in recent years, 
bioengineering technology and molecular technology have been combined with 
bioMEMS technology. Some biocompatible materials have been introduced and widely 
used in bioMEMS fabrication. Therefore, bioMEMS technologies have provided unique 
opportunities to make big impacts in the biomedical, surgical and pharmaceutical fields.  
1.3.2 Introduction to Parylene-based Flexible Technologies 
Parylene is the trade name for a family of semicrystalline thermoplastic polymers 
known as the poly-para-xylylene (PPX). The polymers were discovered in 1947 by 
Michael Szwarc in Manchester, England. There are over 20 types of parylene actually 
developed, but only three have been used on large scales: parylene N (no chlorine on the 
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benzene ring), parylene C (one chlorine on the benzene ring), and parylene D (with two 
chlorines on the benzene ring) (Fig. 5). 
The advantages of using parylene, and more specially, parylene C for in vivo 
applications include high elongation (up to 200%), low Young’s modulus (around 2.8-4 
GPa), FDA approval for chronic human implant (USP class VI), conformal pinhole-free 
vapor deposition, ease of etching in oxygen plasmas, high resistivity, and low 
permeability against water, gasses and ions [39, 40].   
1.3.2.1 Parylene Deposition 
Parylene layers are deposited in a vapor deposition polymerization process [40]. As 
the starting substance, the dimer of a specific parylene type is heated up until it vaporizes and 
later on splits into a monomeric gas. When the gas reaches the deposition chamber, it cools 
down to room temperature and polymerizes on the target. The deposition process allows a 
conformal coating of the target from tall sides and even sharp edges. Typical layer 
thicknesses range from sub micrometers to tens of micrometers.  
1.3.2.2 Parylene Dry Etching 
Parylene is inert to most chemical reagents, so oxygen plasma dry etching is 
usually used to pattern parylene [41]. Photoresist is the most commonly used mask for 
parylene dry etching. The etching rate ratio between parylene and AZ-series photoresist 
is 1:1.6 for soft-baked photoresist. To etch thick parylene exceeding 10μm, aluminum can 
be used as an alternative long-lasting mask. Plasma etching and Reactive Ion Etching 
(RIE) are both used for parylene dry etching. Plasma etching gives an isotropic profile. 
For fine features or critical side-wall profile, RIE is recommended due to its increased 
anisotropy.  
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1.3.2.3 Parylene Adhesion 
It is generally believed that parylene deposited on a hydrophobic surface shows 
good adhesion, and deposition on a hydrophilic surface leads to poor adhesion [42]. Poor 
adhesion is undesirable during device fabrication, because the parylene interface can be 
easily delaminated via chemical attack. For example delamination may occur due to 
hydrolysis if the device is placed in an aqueous environment. One exception is in a 
process step where the parylene membrane needs to be peeled off from the substrate. 
Here, the poor adhesion is clearly favored.  
Parylene shows poor adhesion on oxidized silicon surfaces due to its surface 
hydrophilicity. Hexamethyldisiloxane (HMDS) is the most frequently used chemical to 
reduce the parylene-to-silicon adhesion. This technique is applied when making parylene-
based devices that need to be peeled off from the carrier wafer.  
There are several methods that can enhance the adhesion between parylene and 
silicon. Some chemicals, such as A-174 provided by Specialty Coating Systems (SCS), 
are aimed at enhancing the adhesion by chemical methods. It was also that found 
parylene shows better adhesion on rougher surfaces. Surface roughness and the anchoring 
designs both contribute to the enhanced adhesion. 
1.3.3 Introduction to Parylene-Based Flexible Microimplants 
Due to superior material properties, parylene C has been widely utilized as the 
structure and insulating materials in different implantable devices. A parylene-based 
retinal prosthetic device has been under development to treat age-related blindness 
caused by outer retinal degeneration [43]. It comprises a high-density epiretinal 
stimulating microelectrode array, radio-frequency coils for power and data telemetry, a 
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telemetry-recovery and driving ASIC and a flexible interconnecting substrate for 
integrating all the modules [44].  
1.3.3.1 Parylene–Based Flexible Microelectrode Array 
Flexible parylene-based microelectrode arrays have been microfabricated with 
thin-film platinum on parylene substrate (Fig. 1.5). A single-metal-layer process or a 
dual-metal-layer process could be used to meet the needs of extremely high-density 
stimulation applications. Some electrodes can survive for more than 430 million pulses 
without failing. A chronic implantation study of the mechanical effects of parylene-based 
microelectrode arrays on the retina over a six month follow-up period has shown 
excellent stability [45].  
 
Figure 1.5. Parylene-based high-density microelectrode array. 
1.3.3.2 Parylene-Based Flexible Assembly 
Flexible parylene-based interconnecting substrate has been monotonically 
fabricated with the microelectrode array in the same microfabrication process [46] (Fig. 
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1.6). The substrate has a pocket designed for the ASIC to sit inside. High-lead electrical 
connections have been made by conductive epoxy through a high-yield “squeeze” 
technique.  
 
Figure 1.6. Parylene-based interconnecting substrate with integrated circuit bare die. 
1.3.3.3 Parylene-Based Flexible Power Coil 
Inductive coupling has been chosen as the wireless power transfer scheme for 
retinal prostheses. Given the power consumption of more than 100 mW needed for high-
resolution implant (Fig. 1.7), a power receiver coil with high quality factor is required. 
Various types of MEMS coils have been designed and fabricated using the parylene-
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metal-parylene skin technology. The fold-and-bond technology has been demonstrated to 
be an effective technique to obtain a high-Q coil. The coil has proven to be mechanically 
flexible with good electrical performance [47].  
 
Figure 1.7. Parylene-based flexible MEMS coil for intraocular power transfer. 
1.4 Goal and Layout of the Dissertation 
The work of this thesis is to develop flexible microimplants for clinical and 
biological needs in in vivo sensing. In Chapter 1, the needs of in vivo sensing are 
classified into two types, long-term and short-term. Then, design strategies of 
microimplants for in vivo sensing in terms of hardware implementation are discussed. 
The hardware function modules and challenges of building these modules are identified 
and explored in the following chapters.   
Chapter 2 reports a stretchable impedance sensor manifested as a pair of quasi-
concentric microelectrodes that can be integrated with a cardiac catheter to detect 
unstable intravascular plaque during cardiac catheterization. It is intended to perform 
short-term in vivo sensing and ideally achieve high-accuracy diagnosis. An inflatable 
silicone balloon is added to the sensor to secure a well-controlled contact with the plaque 
in vivo. The stretchable impedance sensors were deployed to the explants of NZW rabbit 
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aorta for detection of lipid-rich atherosclerotic plaques, and to live animals for 
demonstration of balloon inflation and electrochemical impedance spectroscopy (EIS) 
measurements. This chapter formed the bulk of the publication in Biosensors and 
Bioelectronics [48]. 
Chapter 3 develops a flexible sensor membrane for multi-site epicardial ECG 
monitoring of heart regeneration in zebrafish. To meet the requirements of long-term in 
vivo sensing, the sensor membrane went through a series of design optimizations to 
enable long-term biocompatibility and reliable functionality. To further achieve 
continuous monitoring, the wireless operation of the sensor membrane was demonstrated 
by prototyping signal processing, wireless data transmission and wireless power 
management modules on a printed circuit board (PCB). The device was tested on 
neonatal mouse instead of zebrafish because of size and weight limitations. To further 
reduce the size and weight, a parylene-based printed circuit membrane was designed and 
fabricated to replace the PCB. The flexible, light-weight and compact parylene printed 
circuit membrane was monolithically fabricated with sensor electrodes and provided 
mechanical substrate and electrical interconnection for electronic components. The 
miniaturized wireless ECG recording implant can be potentially deployed on small 
animal models and achieve minimally invasive needle injection. The work provided the 
material for a conference proceeding [49] and two journal papers [50] [51] 
Chapter 4 recapitulates the key outcomes of this body of work and how they 
contribute to the field of in vivo biomedical sensing and its hardware implementation. 
Future research initiatives that extend from the work within this thesis are also briefly 
discussed.  
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Chapter 2  Stretchable Balloon-Inflatable 
Impedance Sensor for Intravascular 
Plaque Detection 
This chapter develops a balloon-inflatable impedance sensor for intravascular 
plaque detection during cardiac catheterization. The significance of this clinical need for 
diagnosis is described first. After introducing the sensing strategy of electrochemical 
impedance spectroscopy (EIS), the feasibility and challenges of implementing this 
strategy to intravascular plaque detection are discussed respectively (Section 2.1). A 
novel catheter-based EIS sensor manifested as a pair of quasi-concentric microelectrodes 
was designed, fabricated and characterized (Section 2.2). An inflatable balloon design 
was additionally added to the sensor for a better in vivo contact. In the experiment section 
(Section 2.3), the procedures of sample preparation, ex vivo measurement and in vivo 
measurement are presented in detail and the experimental results showed the capability of 
the sensor to distinguish impedance magnitude and phase differences between different 
types of plaques. Finally, Section 2.4 summarizes the work and compares with other 
state-of-the-art technologies.  
As one type of short-term in vivo sensing, the impedance sensor was initially 
designed with a cardiac catheterization to be minimally invasive. The sensor features a 
novel quasi-concentric microelectrode design which achieved an accurate diagnosis of 
early-stage unstable plaque. Moreover, the inflatable balloon facilitated a well-controlled 
in vivo contact which provides insight to the common challenge for an in vivo sensor. On 
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top of that, the sensor has also presented adequate expandability and stretchability to 
accommodate balloon inflation.  
2.1 Introduction 
2.1.1 Significance of Intravascular Plaque Detection 
Atherosclerosis (also known as arteriosclerotic vascular disease or ASVD) refers to 
the thickening of an artery wall as a result of invasion and accumulation of fatty materials 
[1]. Its development starts with the low-density lipoprotein molecules present in the 
blood stream which get oxidized by free radicals. Once oxidized, LDL (oxLDL) 
molecules in contact with artery endothelium can cause damage to endothelial cells and 
result in increased permeability of the endothelium. Then oxLDL molecules can easily 
migrate into the artery wall. As a result of the damage caused to the blood vessel, an 
inflammatory response is triggered. White blood cells enter the artery wall to ingest 
oxLDL but are not able to process it, and instead they will turn into large foam cells with 
high lipid content. Foam cells die and rupture, further propagating the inflammatory 
response. Eventually, fatty substances, cholesterol, waste products, calcium and other 
substances build up and form a plaque [2]. Fibrous tissue can form a hard cover over the 
affected area known as the fibrous cap (Fig. 2.1). 
Atherosclerotic plaques can narrow the artery, reduce the blood flow and increase 
the blood pressure. But most of the damage is caused when the fibrous cap gets ruptured. 
The formation of a thrombus will slow or stop the blood flow rapidly, leading to tissue 
death in approximately 5 minutes. The two most commonly recognized scenarios are 
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heart attack and stroke which are caused by artery thrombosis to the heart and brain 
respectively [2]. 
 
Figure 2.1. Development of atherosclerosis by oxLDL filtration. 
Atherosclerotic plaques can be classified into stable and unstable ones (Fig. 2.2). 
There are three main differences: (1) the fibrous cap is thicker in stable plaque and 
thinner in unstable plaque. (2) The lipid pool underneath the fibrous cap is comparably 
smaller in stable plaque and larger in unstable plaque. (3) The stable plaques are rich in 
extracellular matrix and smooth muscle cells, while the unstable plaques are rich in 
inflammatory cells such as macrophages and oxLDL-filled foam cells. Therefore, the 
unstable plaque with a thinner fibrous cap over a larger fatty core is more vulnerable. At 
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the same time, the macrophages within the plaque can release enzymes that break down 
collagen in the cap, thus the cap gets weaker and more prone to rupture. Therefore, the 
detection of unstable plaques is of utmost importance and holds the potential to identify 
patients for selective intervention. 
 
Figure 2.2. Comparison of stable and unstable plaques. 
2.1.2 Current Technologies for Intravascular Plaque Detection 
Greyscale (GS) intravascular ultrasound (IVUS) has been widely employed as a 
diagnostic technique for the evaluation of atherosclerotic plaques [3]. However, its 
specificity and sensitivity for tissue identification are limited. In the last few years, in 
order to achieve a more reliable analysis of plaque composition, a spectral analysis of 
IVUS radiofrequency data (RFD) has been developed [4]. Another technique, optical 
coherence tomography (OCT), is a high-resolution imaging modality that uses reflected 
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near-infrared light to visualize vascular microstructures and it has been successfully 
applied for the characterization of coronary atherosclerotic plaques in vivo [5]. 
Intravascular magnetic resonance spectroscopy (IVMR) is a new technique developed to 
identify specifically the lipid component of plaques based on the self-diffusion of water 
molecules that is translated into a lipid fraction index (LFI) [6]. These four imaging 
modalities have in common the ability to give a detailed assessment of the composition of 
atherosclerotic plaques but do differ in the means of achieving this.  
2.1.3 Introduction to Electrochemical Impedance Spectroscopy (EIS) 
The impedance Z of a system actually measures the dielectric properties of a medium 
as a function of frequency [7]. The impedance depends on the interaction between the 
medium electric dipole and externally applied field. Therefore, it can be determined by 
applying a sinusoidal voltage perturbation with a small amplitude and detecting the current 
response. Based on this definition, it can be calculated as: 
Z ൌ ୚ሺ୲ሻ୍ሺ୲ሻ ൌ
௏బ ୱ୧୬ሺଶగ௙௧ሻ
ூబ ୱ୧୬ሺଶగ௙௧ା∅ሻ , 
where V(t) is a voltage-time function and I(t) is the responding current-time function, 
଴ܸ and ܫ଴ are maximum voltage and current signals, f is the frequency, t is the time, and ∅ is 
the phase shift.  
Z is a complex value representing how the current can differ from voltage in terms of 
amplitude and phase as well. The complex Z can be expressed by the modulus |Z| and the 
phase shift ∅, or alternatively by the real part R and the imaginary part X. Accordingly, the 
impedance measurement can be illustrated in two different ways, a Bode plot which plots 
log|Z| and ∅ as a function of logf, or a Nyquist plot which plots R and X.  
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The impedance is measured at different frequencies, so called “spectroscopy”. The 
electrochemical impedance spectroscopy (EIS) is widely used to analyze the complex 
electrical resistance of a system. It can respond to surface phenomena and bulk properties. 
For example, as a biosensor, it can detect the binding events on the transducer surface. With 
the development of instrumentation, EIS has found more applications in characterizing 
surfaces, layers, membranes, and exchange and diffuse processes in recent years [8].  
In order to characterize biological tissue, metallic electrodes must be introduced into the 
system. By applying a sinusoidal stimulating voltage, the current flows through all the 
components of a system, including the working electrode, the biological tissue and the 
counter electrodes. The measured impedance is contributed to by all the individual 
impedances.  
Various equivalent circuit models have been proposed to interpret the impedance 
spectrum. A simple yet efficient model for the electrochemical impedance in tissue is 
represented as a parallel capacitance, CP, shunted by a charge transfer resistance RP, in series 
with the tissue resistance RS (Fig. 2.3). 
 
Figure 2.3. Simplified equivalent circuit model for impedance measurement in tissue. 
2.1.4 Feasibility of Applying EIS to Intravascular Plaque Detection 
Biological tissue such as blood vessels harbor resistance and store charges, exhibiting 
complex electric impedances as a function of frequency. Atherosclerotic plaques harbor pro-
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inflammatory substrates; namely, oxLDL and macrophage-derived foam cells which infiltrate 
and engender distinct electrochemical properties [9]. Hence, it is feasible to determine the 
plaques’ frequency-dependent electrical and dielectrical behavior by recording the electric 
impedance of a tissue over a frequency range. Since the electrical properties of biological 
tissues are related to their physiological and morphological properties, EIS is suitable for the 
detection of tissue composition and could potentially identify plaques that are prone to 
rupture.  
2.1.5 Challenges of Implementing EIS in Intravascular Plaque Detection 
 There are several challenges to the implementation of EIS for intravascular plaque 
detection.   
 First, for in vitro sensing applications, a large surface area provided by the inert 
platinum or carbon electrode is commonly used as the counter electrode, providing both high 
charge transfer resistance and double-layer capacitance. The overall impedance contributed 
by counter electrode is considered negligible. For intravascular EIS applications, where a 
high spatial resolution is necessary, the confined space in the catheters warrants close 
packaging of both the counter and working electrodes. For this reason, EIS measurements 
must account for the electrochemical interference at both the counter and working electrode 
interfaces. 
 Secondly, because of the non-homogeneous tissue composition and uneven 
endoluminal topography, the current distribution generated from applying voltage to the 
impedance electrodes will be uneven. This is different from ex vivo impedance 
measurement, where the plaques under test and the placement of impedance sensors 
could be visually adjusted and aligned to compensate. Therefore, a modified electrodes 
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design and an improved arrangement of the working electrode and counter electrode are 
needed.  
 Thirdly, a stable and proper contact of the electrodes with the plaque under test is 
very important to enhance the qualities of the recorded signal. An external force that can 
push the electrodes towards the plaque and keep the electrodes in contact is ideal. 
Considering the plaques tendency to rupture, the applied force needs to be small and 
gentle. An additional sensor feature was considered here to provide this well-controlled 
pushing force in vivo. 
2.2 Catheter-based Balloon-Inflatable Quasi-Concentric EIS 
Microelectrode Sensor 
2.2.1 Design  
To facilitate the detection and diagnosis of the non-obstructive and pro-
inflammatory atherosclerotic plaque, a pair of quasi-concentric microelectrodes, 
integrated onto an inflatable silicone balloon, was designed to adhere to a catheter tip to 
perform the EIS in vivo sensing during catheterization. 
For the impedance sensing, the central and outer microelectrodes are arranged in a 
concentric configuration (Fig. 2.4). The diameter of the solid central microelectrode is 70 
m and the inner and outer diameters of the annulus outer microelectrode are 100 m and 
300 m respectively. To achieve this concentric configuration on a single metal layer, a 
small gap is opened on the outer microelectrode for the routing out of central 
microelectrode. Although the tiny gap breaks the perfect symmetry of the concentric 
electrodes, it allows single-layer metal deposition and one-side electrode openings in the 
fabrication of the device. This can greatly reduce the cost, simplify the process and 
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increase the yield. More importantly, the central and outer microelectrodes, i.e., the 
working and counter electrodes, are fabricated monolithically and have exactly same 
surface properties.  
The quasi-concentric microelectrodes are connected to the contact pads through 
sinusoidal lines for an improved expandability and stretchability during balloon inflation. 
The contact pads establish electrical connections with the external energy source through 
medical-grade coaxial wire, and supply the excitation voltage across the central and outer 
microelectrodes.  
There are four major advantages to this design: (1) The quasi-concentric 
configuration can provide constant and symmetric displacement currents between 
working and counter electrodes. (2) The quasi-concentric electrodes may allow for EIS 
measurement independent of the surrounding solutions or blood and the orientation of the 
tissues. (3) The fabrication process and post connecting process for making the quasi-
concentric electrodes are simple and reliable. (4) The small dimensions of the 
microelectrodes can achieve a higher spatial resolution in the regions of pro-
inflammatory states. (5) The small separation between the working and counter 
electrodes make the measured impedance mainly sensitive to tissue in close proximity 
and independent of the lumen diameters, blood volumes and flow rates when the in vivo 
contact is made.  
An inflatable silicone balloon is designed to inflate in vivo and push the electrodes 
towards the plaque. To integrate the impedance sensor onto the silicone balloon, two 
meshed anchoring pads with nine through holes on each side are designed to be 
monolithically fabricated with the sensor. A small amount of additional epoxy applied on 
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the anchor pads permeates the through holes and bonds together with the silicone balloon 
body. Because the balloon mainly expands in the radial direction, the sinusoidal cables 
mostly extend in the longitudinal direction.  
 
Figure 2.4. Quasi-concentric microelectrode sensor design. 
2.2.2 Fabrication 
The fabrication process required four main steps: (1) Fabrication of the silicone 
balloon. (2) Assembly of the sealed tubing connecting the balloon to a syringe. (3) 
Microfabrication of the impedance sensor. (4) Securing the impedance sensor to the 
balloon (Fig. 2.5).  
First, steel tubing with a tip outer diameter (OD) of 0.008 200 μm (McMaster-
Carr,  Santa Fe Springs, CA) was immersed in AZ9260 photoresist (AZ Electronic 
Materials, Branchburg, NJ), followed by a baking process for 10 minutes at 100oC. A 
second coating was then applied and baked for 10 minutes to form the inner layer of the 
balloon. Nusil 6820 silicone (Nusil Technology LLC, Carpinteria, CA) was used for its 
low Young’s modulus (4.4 MPa) and high elongation (175%). The silicone was 
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thoroughly mixed in a 1:1 ratio of part A and part B, and then painted onto the surface of 
PR and the capillary tubing. An opening was intentionally created for the subsequent PR 
release. Ensuring an even coverage of the balloon is important for symmetrical inflation. 
The modulus of elasticity increased with increased curing duration and temperature. 
Afterwards, it was fully submerged into a beaker of acetone to dissolve the PR, thereby 
forming the cavity and allowing for the removal of the inner steel tube. The hole on the 
top was further sealed with silicone paint. The balloon was set over a parylene-coated 
silicon wafer and baked for 10 minutes at 100 ̊C. Parylene C facilitated peeling of the 
balloon, and resting of the sensor on a wafer created a planar surface on the balloon for 
securing the impedance sensor.  
 
Figure 2.5. Fabrication process of the catheter-based balloon-inflatable microelectrode 
sensor. 
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In parallel, a 30 gauge Luer-lok needle was epoxied into a 5 cm section of similar 
capillary tubing. The free end of the tubing was then epoxied over a 30 cm section of 200 
μm steel tubing. The steel tubing was more flexible and less brittle than the capillary 
tubing, rendering the overall device more robust for intravascular interrogation. This 
assembly was cured in an oven at 100 ̊C, and checked for blockage by pushing air into a 
beaker of water via a syringe. The entire device was then dried in an oven. The open end 
was inserted into that of the balloon’s capillary tubing and secured into place. The epoxy 
was spread over the silicone in contact with the capillary tubing to prevent balloon 
delamination. 
To fabricate the impedance sensor, a 5-µm-thick bottom parylene C was 
deposited onto a hexamethyldisilazane-treated (HMDS) silicon wafer. Then a metal layer 
of Titanium/Gold (Ti/Au) (0.02 µm /0.2 µm) was deposited by thermal evaporation and 
patterned by chemical wet etching. After the deposition of another 5-µm-thick parylene C 
layer, the impedance-sensing microelectrodes and contact pads were patterned by oxygen 
plasma etching. The overall device outlines were finally defined by etching through the 
parylene C layer. The device was then peeled off from the silicon substrate.  
To assemble the impedance sensor to the balloon, the quasi-concentric impedance 
sensor was attached by applying biocompatible epoxy to the flat side of the balloon with 
the sensor openings facing up. Next, the two contact pads were connected to a coaxial 
wire using biocompatible conductive epoxy, and then fully encapsulated and fixed onto 
the tubing by silicone (PDMS) (Fig. 2.6). The sinusoidal-line connecting the sensing 
electrodes and the pads allowed a stretchable sensor in response to bubble inflation.  
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Figure 2.6. (a) The impedance sensor was mounted on a balloon. (b) SEM photo of the 
finished impedance sensor, highlighting the stretchable sinusoidal cables in response to 
balloon inflation and the two gluing pads allowed for affixation on the surface of the 
balloon. 
2.2.3 Characterization 
2.2.2.1 Impedance Characterization 
The impedance sensor with inflatable balloon was placed inside electrolyte-rich 
blood for impedance characterization and for determining the EIS measurements’ 
baseline. An input of 10 mV peak-to-peak AC voltage and frequency sweeping from 300 
kHz to 100 Hz were delivered to the microelectrodes. The magnitudes and phases of the 
impedance were acquired at 20 data points per frequency decade. The baseline 
measurement is shown in comparison to the following ex vivo and in vivo measurements.  
2.2.2.2 Inflation Pressure Characterization 
The catheter-based impedance sensor with inflatable balloon was deployed into 
the phosphate saline buffer-filled explants of aorta in which EIS measurements were 
performed to determine the optimal inflation pressures (Fig. 2.7). At pressures below 6 
psi, the balloon was not fully inflated, and sensor was not in contact with the endoluminal 
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surface. The EIS measurements revealed a baseline impedance of 70 kΩ at low frequency 
and more resistive behavior at a higher frequency, accompanied by -40 to -45 degrees of 
phase. At 7 psi, the inflated balloon enabled the microelectrodes to make contact with the 
vessel wall, resulting in a significant change in the impedance spectrum. At low 
frequencies, the magnitude of the impedance increased to 300 kΩ. At higher frequencies, 
the magnitude of the impedance decreased, as the vessel wall was more capacitive 
compared to saline, accompanied by a decrease in phase to -60 degrees at 100 kHz. At 9 
psi, a slight decrease in magnitude and phase were observed, implicating a higher 
pressure applied by the balloon to the vessel wall, causing local deformation. Hence, our 
observations suggest that 7 psi is an optimal inflation pressure for EIS measurements 
with full surface contact and minimum applied force to the endoluminal surface. It is 
recognized that intravascular blood pressure is considerably higher than atmospheric 
pressure or the pressure in saline, so that the balloon in vivo may not be able to be 
inflated to the same level in vitro.  
However, it has been demonstrated that EIS is a powerful tool which can detect 
when the sensor becomes in contact with the vessel wall. The impedance of blood is 
significantly lower than that of vascular tissue due to its electrolyte-rich fluid nature, thus 
the contact between sensor and vascular wall can be detected by observing the significant 
impedance increase as balloon inflates. This feature allows us to fine tune the balloon 
inflation in vivo. 
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Figure 2.7. Inflation pressure characterization in vitro (a) The balloon-inflatable 
impedance sensor was inserted into the ex-vivo rabbit aorta. (b) Demonstration of balloon 
inflation prior to impedance assessment. (c) Demonstration of intravascular balloon 
inflation. 
 
Figure 2.8. Characterization of balloon-inflatable impedance sensor in terms of 
frequency-dependent changes in impedance magnitude and phase.  Data were collected in 
response to balloon inflation at 5, 6, 7 and 9 psi, respectively. The data revealed that 7 psi 
was sufficient for adequate contact between the sensor and vessel wall as it showed a 
significant change in the values at the whole frequency band with magnitude and at 
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frequencies above 30 kHz with phase. At 9 psi, the balloon was over-inflated 
representing a slight decrease.  
2.3 Experiments and Results 
2.3.1 Sample Preparation 
In compliance with the Institutional Animal Care and Use Committee (IACUC) at 
the University of Southern California, four male New Zealand White (NZW) rabbits (10-
week-old: mean body weight ~ 2 kg) were purchased from a local breeder (Irish Farms, 
Norco, CA). NZW rabbits are established as a model of atherosclerotic biology with 
plaques accessible to catheter interrogation. Two animals were fed a high-fat, high 
cholesterol diet (Newco® 1.5% cholesterol & 6% peanut oil). After 8 weeks, explants of 
aortas were interrogated for intravascular electrochemical impedance spectroscope (EIS). 
Another two animals were used for feasibility of in vivo EIS measurements. 
The rabbits were anesthetized for percutaneous access. Intravascular ultrasound 
(IVUS) probe and microelectrode sensor were sterilized by Electron Beam technology 
(Titans SureBeamTM) and heparinized to prevent thrombosis. A femoral cut-down was 
performed and a 2-French (distal O.D.) Tracker-10, 80/15 guide catheter (Target 
Therapeutic) was inserted under binocular magnification and heparin administered (150 
units/kg). The catheter and a Dasher-14 Steerable Guide wire (Target Therapeutic) were 
then advanced under fluoroscopic guidance (Phillips BV-22HQ C-arm) into the aortic 
arch. The catheter was withdrawn to the thoracic aorta, and lastly, abdominal aorta, for 
similar interrogations.  
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2.3.2 Ex Vivo EIS Measurements in Fat-Fed NZW Rabbits 
EIS measurements were performed in explants of fat-fed rabbit aorta via the 
balloon-inflatable quasi-concentric microelectrodes. Similar to the previous inflation 
pressure characterization (Fig. 2.7), inflation of the balloon enables the sensor to be in 
contact with the endoluminal surface, and significant changes in both impedance and 
phase spectra were observed (Fig. 2.9). Immunohistochemistry revealed plaque versus 
plaque-free sites in the insets, respectively (Fig. 2.9a and 2.9b). Balloon inflation-
mediated endoluminal contact induced an approximately 20% increase in impedance 
from 1 kHz to 100 kHz, and a decrease in phase at a frequency above 50 kHz (n=4). EIS 
sensor contact with the atherosclerotic plaques further resulted in a greater than 50% 
increase in the impedance spectrum over the entire frequency range (n =4), accompanied 
by a decrease in phase at the lower frequency range (1 kHz – 10 kHz), reflecting a 
capacitive property of the tissue. Histological analysis confirmed the presence of foam 
cell-rich fatty deposition in the endoluminal vessel wall at the plaque sites in contrast to 
the plaque-free site with an intact tunica intima layer (inset in Fig. 2.9b). Hence, the 
feasibility of the balloon-inflatable concentric microelectrodes for intravascular 
interrogation of atherosclerotic plaques was demonstrated. 
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Figure 2.9. Ex-vivo EIS acquisition from explanted rabbit aorta and corresponding 
histology of the aorta wall.  After 8 weeks of high-fat diet, rabbits were sacrificed and 
aortas were extracted and fixed in 15% paraformal aldehyde (PFA). The individual aortas 
were sectioned into 2-3cm segments and immersed in PBS for deployment of the 
balloon-inflatable EIS sensor. Endoluminal lipid deposition or atherosclerotic plaques 
were visible for EIS interrogation and comparison with the disease-free sites. (a) After 
the balloon inflation, the impedance magnitude increased over the entire frequency range 
from 1 kHz to 1,000 kHz.  EIS measurement further increased significantly at the plaque 
sites. (b) Corresponding histology revealed intact tunica intima and media layer at 
plaque-free sites, and accumulation of foam cells at plaque sites.  
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2.3.3 In Vivo EIS Measurements in NZW Rabbit 
The deployment of the catheter-based balloon EIS sensor to interrogate carotid 
arteries of NZW rabbits has been further demonstrated (Fig. 2.10). The angiogram 
revealed the position of the catheter in relation of the EIS sensor. The impedance of in 
vivo measurements displayed a distinct phase spectrum compared to those of the ex vivo 
findings (Fig. 2.9b) towards the lower frequency range. Both blood serum and vessel wall 
were more resistive, as reflected in a higher phase changes at -34.1±1.6 and -30.4±0.3 
degrees, respectively (n = 6). However, the impedance spectra in the frequency range of 
10 kHz to 300 kHz displayed a similar pattern to those of ex vivo (Fig. 2.9a). Balloon 
inflation induced an increase in impedance and a decrease in phase towards the higher 
frequency range.  
 
Figure 2.10. Deployment of balloon-inflatable EIS sensors via fluoroscopy guidance in 
NZW rabbits. The position of EIS sensor was visualized in the carotid artery. 
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Figure 2.11. In-vivo EIS acquisition in the rabbit carotid arteries.   Balloon-inflatable EIS 
sensor packaged onto an in-house-built balloon catheter. The catheter was deployed 
through right carotid artery cut-down and the sensor made endoluminal contact under the 
fluoroscopic guidance. Inflation of the balloon resulted in a significant increase in the 
frequency-dependent impedance magnitude, from 10 kHz to 300 kHz, along with distinct 
phase characteristics. 
2.4 Discussion 
The novelty of the study lies in the intravascular deployment of flexible and 
stretchable intravascular EIS technology to assess oxLDL-rich atherosclerotic plaques. 
Biological tissues possess energy storing and dissipation properties, thus could be 
detected and classified by endoluminal EIS measurement. The use of a linear array of 
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electrodes has been utilized, but showed limits in size as well as capability to detect small 
and non-homogenous plaques [10-12]. The concentric microelectrodes enabled highly 
sensitive EIS measurement of the electrochemical tissue properties at close proximity 
without interference from the surroundings.  
The features of flexible and stretchable electronics have made real-time 
endoluminal assessment of lipid-rich plaques possible. Here, stretchable sensors have 
been characterized in terms of distinct changes in impedance and phase spectra in 
response to various pressures of balloon inflation (Fig. 2.9). Baseline EIS measurements 
before and after balloon inflation were established, followed by the comparison of EIS 
magnitudes in the presence or absence of lipid-rich plaques. The inflation of the balloon 
at 7 psi enabled the EIS sensors, in minimal contact with the endoluminal surface, 
providing significant differences in both impedance magnitude and phase changes at 
frequencies above 30 kHz (Fig. 2.9 and 2.11). Thus, the first intravascular impedance 
sensor that is both flexible and stretchable for in-vivo applications was demonstrated.  
Oxidized low density lipoprotein (oxLDL) induces transformation of 
macrophages to lipid-laden foam cells [13]. Activated macrophages secrete matrix 
metalloproteinase (MMPs) to mechanically destabilize plaques [14, 15]. Growing 
evidence suggests that oxLDL and thin-cap fibroatheromas (TCFA), rich in 
macrophage/foam cells, are prone to mechanical stress and destabilization [16-18]. Using 
the novel concentric microelectrode sensor, it was demonstrated that oxLDL-laden foam 
cells in the subendothelial layer of plaque significantly increased the frequency-
dependent EIS magnitude in New Zealand White (NZW) rabbits on diet-induced 
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hyperlipidemia. Elevated EIS signals were reproduced in the oxLDL-rich, but not 
oxLDL-free, plaques [19].  
An equivalent circuit model was provided here to illustrate the EIS measurement 
in intravascular tissue. Briefly, EIS measures intrinsic electrochemical properties of the 
tissue which depend on the chemical composition of the local tissue at the vicinity of the 
sensor. In particular, water content, electrolyte concentration and lipid content are a few 
of the most important factors affecting tissue impedance. Accumulation of oxLDL at the 
measurement site would significantly reduce water content, which is essentially the 
electrical conduction pathway, resulting in higher tissue impedance to electrical input 
signals, as well as more capacitive effect at high frequency. As demonstrated previously, 
it is feasible to establish a correlation between the status of the plaque and the resulting 
impedance in a certain frequency range, thus allowing accurate detection of the oxLDL-
rich, mechanically unstable plaques. 
 
Figure 2.12. Equivalent circuit of the in vivo impedance sensing configuration. 
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In summary, this current study presents the use of a robust and innovatively 
designed balloon-inflatable catheter-based concentric EIS sensor that could be used for 
the detection of endoluminal electrochemical properties. The demonstrations on explants 
from fat-fed NZW rabbit aortas and carotid arteries via in-situ and in-vivo trials further 
confirmed the link between endoluminal properties with pre-atherosclerotic plaques. The 
new features of real-time measurement as well as the stretching capability offer potential 
for clinical monitoring and integration with emerging flexible electronics for diagnosis 
and prognosis. 
2.5 Conclusion 
This work demonstrated the feasibility of stretchable electrochemical impedance 
spectroscopy (EIS) sensors for endoluminal investigations in New Zealand White (NZW) 
rabbits. The parylene C-based impedance sensor was mounted on the surface of an 
inflatable silicone balloon affixed to the tip of an interrogating catheter. The stretchable 
EIS sensors were deployed to the explants of NZW rabbit aorta for detection of lipid-rich 
atherosclerotic plaques, and to the live animals for demonstration of balloon inflation and 
EIS measurements. An input peak-to-peak AC voltage of 10 mV and sweeping-frequency 
from 300 kHz to 100 Hz were delivered to the endoluminal sites. Balloon inflation 
allowed EIS sensors to be in contact with the endoluminal surface. Impedance magnitude 
increased in the entire frequency band by 1.5-fold and the phase dropped by ~5 degrees at 
frequencies below 10 kHz in the oxLDL-rich plaques in response to balloon inflation in 
the explants of aortas from fat-fed rabbits. In the plaque-free sites of the normal diet-fed 
rabbits, impedance magnitude increased by 1.2-fold at frequencies above 30 kHz and 
phase shifted by ~5 degrees. The feasibility of stretchable EIS sensors for endoluminal 
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interrogation was demonstrated; providing a new intravascular strategy to identify high-
risk plaques. 
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Chapter 3 Flexible Microelectrode 
Membrane for Epicardial ECG 
Recording 
Chapter 3 describes a flexible microimplant for long-term epicardial 
electrocardiogram (ECG) signals recording to assess heart regeneration in small animal 
models, which remains one of the most challenging scenarios in in vivo sensing.  
Section 3.1 introduces the significance of long-term ECG recording in heart 
regeneration processes, discusses the hardware implementation of a typical ECG 
recording system, lists various wired, wearable and implantable ECG recording systems, 
and identifies specific challenges associated with a long-term ECG recording system for 
heart regeneration monitoring. Following that, section 3.2 develops a long-term wearable 
parylene C membrane containing multiple microelectrodes. The microelectrode 
membrane can be percutaneously implanted and can record epicardial ECG signals from 
specific regions of zebrafish heart. However, with this passive microelectrode membrane, 
animals need to be sedated and external connections need to be made for each 
measurement. Therefore, section 3.3 further demonstrates the wireless operation of the 
microelectrode membrane with a wireless ECG recording system prototyped on a printed 
circuit board (PCB). ECG signals were continuously recorded and wirelessly transmitted 
from a non-sedated neonatal mouse model of heart regeneration. To accomplish a 
substantial miniaturization of the PCB prototype, a parylene C printed circuit membrane 
platform for flexible circuit integration is presented in section 3.4. The circuit membrane 
layout design and assembly techniques of different small components were formulated 
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individually and configured collectively. The same wireless ECG recording system was 
demonstrated on a flexible, light-weight and compact parylene C printed circuit 
membrane with the ECG recording microelectrodes monolithically manufactured on the 
same membrane. Conclusions are summarized in section 3.5. The presented flexible, 
light-weight and compact wireless ECG recoding implant could potentially be injected by 
needle and achieve minimally invasive long-term in vivo monitoring. 
3.1 Introduction 
In human, myocardial infarction results in irreversible loss of heart tissues or 
cardiomyocytes [1].  The limited capacity of the heart to regenerate injured tissue often 
leads to heart failure which afflicts nearly five million people in the US with an 
additional half million diagnosed each year. Despite current diagnosis and therapy 
regimens, heart failure remains the leading cause of morbidity and mortality in the US 
and developed world  [2].  
In contrast, certain fish and amphibians maintain a regenerative capacity 
throughout the adult life. Zebrafish possess a remarkable capacity to regenerate a 
significant amount of myocardium in injured hearts [3]. Due to the relatively ease of 
maintenance and breeding, they present a genetically tractable model system for high 
throughput regenerative medicine and cardiovascular research [4].  
3.1.1 Significance of ECG Recording in Heart Regeneration 
Zebrafish heart regeneration has been characterized using molecular, genetic and 
immunohistochemical approaches; however, the cardiac conduction phenotype in the 
injured and regenerated cardiomyocytes remains unknown [5]. Zebrafish myocardium 
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can fully regenerate after 20% ventricular resection over a period of 60 days, as 
evidenced by histology (Fig. 3.1), while whether the structurally regenerated 
myocardium displays functionally normal conduction phenotype remains undefined [3].  
 
Figure 3.1 Heart regeneration in zebrafish model. In response to ventricular amputation, 
thrombosis immediately develops to achieve homeostasis in the ventricle. The thrombus 
is replaced by a fibrin clot 2-4 days post amputation (dpa). Nascent cardiomyocytes 
replace the vast majority of the lost ventricular tissue by 30 dpa, and the structure of the 
ventricle is fully restored on 60 dpa without scar tissue. The scale bars are measured 100 
m.  
ECG records the action potential of heart muscle cells and shows their electrical 
activities in the functional dimension. Myocardium cells are like little batteries. They 
have different ion concentrations inside and outside their membranes, which create small 
electric potentials. A disturbance in this electric potential can give rise to an action 
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potential which is the depolarization and repolarization of the cell. Essentially, ECG 
signals are composed of the superposition of the different action potentials from heart 
muscle cells.  
A typical ECG waveform consists of three primary characteristics: the P wave, 
the QRS complex, and the T wave (Fig.3.2). Each wave corresponds to the electrical 
activity of a specific region of the heart. The P wave comes first and represents the 
depolarization of the atria. The QRS complex represents depolarization of the ventricles, 
and is usually the strongest wave in an ECG. The last wave is the T wave and it 
represents the repolarization of the ventricles. The repolarization of the atria is usually 
hidden in the QRS complex and becomes the most challenging characteristic to be 
detected.  
 
Figure 3.2. A typical ECG waveform and the characteristics: the P wave, the QRS 
complex and the T wave. 
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ECG recording during the heart regeneration process can be used to assess the 
cardiac conduction in response to induced heart injury and to analyze the dynamic signal 
evolution during regeneration, thus providing a tool for the study of the mechanistic 
information for the regeneration process and the functional integration of the regenerated 
cells and host tissue [6].  
Despite having a two-chambered heart, the zebrafish heart ECG is fundamentally 
similar to that of humans in terms of P waves, QRS complexes, and T waves [7]. The 
critical conduction pathways of the zebrafish in cardiovascular development also parallel 
that of higher vertebrates. Because cardiac development, structure, and function are 
relatively conserved between lower vertebrates and mammals, further mechanistic 
investigations may yield future insights into cellular therapies for human heart failure and 
myocardial infarctions [8].  
3.1.2 Introduction to ECG Recording System 
ECG has been long used as a diagnostic tool for medical evaluation. The ECG 
waveform allows cardiologists to infer information about the electrical activity associated 
with different aspects of a heart beat and is of particular value for assessing an 
individual’s cardiac rhythm and heart health [9].  
The heart pumps blood around the body using a carefully controlled order of 
contractions of its chambers. The contraction of a muscle cell is a result of a 
depolarization and repolarization cycle called an action potential during which the 
potential difference between the inside and outside of the cell changes. Considering all 
the cardiac cells together, the heart can be viewed as an electrical generator which drives 
current into a passive resistive medium around the heart [10]. By taking the voltage 
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differences at different points in the surrounding medium, the electrical activity of the 
heart can be observed. The ECG signals represent the electrical activity of an ensemble of 
cells in the myocardium.  
To record the ECG, a sensor that can convert the ionic potentials generated by the 
heart into electronic potentials which can be measured by the conventional electrical 
circuitry is needed. Following that, due to weak signals, amplification and filtering are 
required to provide high-quality signals for further transmission, display and analysis.  
A completely ECG recording system should have all of the four function modules 
described in Chapter 1, including signal sensing, signal processing, data transmission and 
power transmission [14, 15, 16]. With particular relevance to ECG recording, some 
general design references for each individual module are discussed here.  
(1) Signal Sensing: 
ECG recording sensors are transducers that convert ionic potential to electrical 
potential. They typically consist of a pair of electrodes. Electrodes, based on the materials 
used, can be classified into polarizable, in which case they are modeled as capacitors, or 
non-polarizable, in which case they behave like resistors [11]. Current flow across the 
electrode-electrolyte interface is minimal for recording electrodes, so there are no high-
rate electrochemical challenges to the electrodes.  
(2) Signal Processing: 
The strength of ECG signals can vary from the microvolt to millivolt range [12]. 
Signals picked up by the sensors need to be amplified before being interpreted. On the 
other hand, ECG signals are subject to many different kinds of noise, internally and 
externally, during recording, which depend on the data and power transmission schemes, 
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including the 50/60 Hz pick-up signal, baseline drift, baseline instability, and muscle 
mechanical movement. These artifacts can be filtered digitally on the software side as 
well as through analog practices on the hardware side.  
(3) The power and data transmissions: 
The power and data can be transmitted through wires or wirelessly.  For a 
completely wireless system, signals need to be transmitted through multiple media 
between the transmitter and receiver side, air, water and biological tissue, by modulating 
different energy forms like electromagnetic waves, light and ultrasound  [13]. Recording 
usually consumes relatively less power. The power source of a wireless ECG recording 
system could be a battery, biomechanical and biochemical energy harvester, or inductive 
link [14].  
 
Figure 3.3 Hardware implementation of typical ECG Recording Systems 
3.1.3 Overview of Current ECG Recording Systems 
Current ECG recording systems can be classified into three categories: wired, 
wearable and implantable (Fig. 3.4). 12-lead ECG taking a differential measurement of 
the electrical potential on the body surface at different locations generates different ECG 
vectors. Six of these leads are in the plane parallel to the body and are known as “frontal” 
ECG leads. The other six ECG leads are views of the heart in the plane perpendicular to 
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the body and are known as “pre-cordial” leads. The wearable ECG patch from WIN 
Human Recorder forms single lead and achieves long-term ECG monitoring during 
normal activity. The implantable ECG is from Medtronics which can be implanted for 3 
years and staying functional in vivo. It is fully encapsulated inside a metal case and 
measures 62 mm in length.  
 
Figure 3.4 Current ECG recording systems: wired, wearable and implantable.  
3.1.4 Challenges of Implementing ECG Recording System in Zebrafish 
for Heart Regeneration Monitoring 
The application of heart injury and regeneration monitoring poses unique 
challenges on the design and implementation of ECG recording systems, especially for 
small animal models such as zebrafish.  
  First of all, animal models of heart regeneration are typically induced with 
different heart injuries to different extents, mechanically or genetically [15]. So it is 
desirable to implement multi-channel ECG recording corresponding to specific regions 
on heart. ECG signals of zebrafish were previously recorded using a pair of needle 
electrodes [16]. A long QT interval was experimentally observed during heart 
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regeneration. Compared to this global ECG signal recording, region-specific recordings 
can potentially uncover the aberrant cardiac currents of the injured and regenerating heart. 
In order to record from a little tiny heart with high spatial resolution, electrodes with 
small dimensions and proper mechanical fixtures to keep the electrode in close proximity 
to heart surface are needed. To tackle this challenge, section 3.2 demonstrates a long-
term wearable membrane with the four embeded microelectrodes percutaneously 
implanted into zebrafish heart for epicardial ECG recording. It is also demonstrated here 
the feasibility of using ECG signals as a functional characterization of heart injury and 
heart regeneration. 
Secondly, heart regeneration can take up to two months [17]. A wireless and 
continuous recording would be ideal, otherwise animals need to be sedated and electrical 
connections have to be made for every ECG measurement. Section 3.3 describes the 
continuous and wireless operation of the wearable microelectrode membrane. The signal 
processing, data transmission and power management modules were prototyped on a 
printed circuit board. Wireless recording was demonstrated on a non-sedated neonatal 
mouse.  
Thirdly, the wireless recording system for long-term ECG morning can be useful 
only under the condition that the wireless ECG recording system does not cause any 
burden or stress on the animal models. Otherwise, the ECG signals can be influenced. 
Given the small dimensions of zebrafish and zebrafish hearts, only an extremely flexible 
and miniaturized wireless ECG system is applicable for zebrafish. Section 3.4 presents 
the same wireless ECG recording system implemented on a flexible, lightweight and 
compact parylene C printed circuit membrane.  
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3.2 Wearable Microelectrode Membrane 
In this section, a wearable microelectrode membrane was developed to achieve 
multi-channel region-specific ECG recording over a prolonged period. The membrane 
was percutaneously implanted into zebrafish through open chest surgery and carried by 
the fish during normal swimming. ECG signals were obtained periodically in air with the 
zebrafish sedated. Aberrant cardiac ECG signals were observed with injured and 
regenerating hearts.  
3.2.1 Design 
The microelectrode membrane, with titanium/gold recording electrodes embedded 
in parylene C and selectively exposed at recording sites, was designed. In consideration 
of the long-term recording requirement, parylene C was chosen as the substrate and 
insulating material due to the well-suited combination of good biocompatibility (FDA 
approved, USP class VI) and low permeability against water, gases, and ions. 
Titanium/gold was chosen as the electrode material because of good biocompatibility.  
The zebrafish measures about 3-4 cm in length and the fish heart has a diameter 
of only 1 mm [3]. Therefore, the total length of the microelectrode membrane is only 12.8 
mm and all the recording electrodes stay within a circle of 1 mm diameter (Fig. 3.3). Four 
recording electrodes with different diameters of 300 µm, 200 µm, and 100 µm were 
arranged in a diamond shape to access the atrium, apical ventricle, and left and right 
edges of the ventricle. 
The membrane has a five-layered stack structure: an underlying ground layer 
exposed to bias the fish body to the circuit ground, a patterned signal layer including the 
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recording electrodes, cables and connecting pads, and three insulating parylene C layers 
on the top and the bottom and in the middle.  
The membrane has a central strip with one end composed of four percutaneous 
electrodes implanted onto the chest epicardially and the other end connected to a flexible 
flat cable (FFC) end for external circuitry connection. The two side wings with three 
suture holes on each side form a length-adjustable belt wrapping around the fish body 
posterior to the pectoral fin to fixate the device.  
 
Figure 3.5. Device design. (a) Top-view of the overall device geometry; (b) ground and 
signal metal layouts; (c) the side-view of device placement after implantation; (d) the 3D 
view of device fixation. 
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3.2.2 Fabrication  
A 5-µm-thick bottom parylene C layer was first deposited onto a 
hexamethyldisilazane-treated (HMDS) silicon wafer. Next, the ground metal layer of 
Ti/Au (0.02 µm/0.2 µm) was deposited by thermal evaporation and patterned by chemical 
etching. After a 5-µm-thick middle PA-C layer was deposited, the signal metal layer was 
deposited and patterned and a subsequent 5-µm-thick top PA-C layer was deposited in 
the same way. Then, the recording electrodes and connecting pads on the signal metal 
layer, and the biasing electrodes and connecting pads on the ground metal layer were 
opened by oxygen plasma etching. The overall device outlines were finally defined by 
etching through the structural parylene layers. The membrane was then dry-peeled off 
from silicon substrate.  
Thermal treatment was applied to generate the specific curvature for the electrode 
array end to better capture the ventricle contour after implantation. The post assembly 
with the customized FFC cable end resulted in the pluggable connection, with external 
circuit and light implant, for fish to carry. 
 After thermal annealing, an upward warp matching the ventricle contour was 
produced at the electrode array end. The connecting pads were electrically connected to a 
customized FFC cable end via conductive epoxy, and the biocompatible 
polydimethylsiloxane (PDMS) was applied to establish the electrical insulation and 
enhance the mechanical strength.  
The geometry design for the implantation end and the upward curvature provided 
a lock-in mechanism, hence a good epicardial contact with the heart ventricle after 
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insertion (Fig. 3.5). The device has a total weight of less than 50mg, and a thickness of 
less than 0.5mm with FFC cable attached. It was demonstrated to have no observable 
impact on zebrafish’s posture or swimming capabilities. 
 
 
Figure 3.6. Fabrication process of the microelectrode membrane.  
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Figure 3.7. Microelectrode membrane after annealing and assembling.  
3.2.3 Characterization 
The impedance model of the electrode-electrolyte interface and magnitude of the 
impedance are important for designing a recording system. The interface formed by the 
planar metal electrode and conductive fish body fluid can be modeled as a capacitor in 
parallel with a resistor. In the low frequency range (up to 100 Hz) where zebrafish ECG 
signal concentrates, the capacitor dominates and the value is proportional to the interface 
area, i.e. the electrode opening. Smaller electrodes will result in higher spatial resolution, 
while the higher interface impedance may cause significant voltage drop across the 
interface. The zebrafish heart measures 1 mm in diameter. To accommodate four 
electrodes as designed in this extremely limited area, the maximum diameter of each 
electrode is about 300 µm.  Therefore, electrodes with diameters of 50 µm, 100 µm, 200 
µm and 300 µm were compared in terms of the impedance modulations up to 300 KHz 
(Fig. 3.6). Microelectrodes with diameter of 300 m showed best signal strength 
compared to smaller microelectrodes.  
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Figure 3.8. Microelectrode model and magnitude of electrode impedances with different 
dimensions.  
3.2.4 ECG Recording from Zebra Fish 
3.2.4.1 Animal Preparation 
Sedated adult zebrafish (in 0.04% Tricaine methane sulfonate - Tricaine) were 
placed on a damp sponge for a stereo microscope operation of an open-chest procedure. 
Ventricular injury was induced by applying a liquid-nitrogen-chilled metal probe 
(diameter 0.8 mm) for 24 seconds. The fish was returned to the fresh water for recovery.  
After 3-7 days, the fish underwent MEA implantation. A 2-mm-long horizontal 
incision was created at 0.5 mm caudal to the heart. The membrane can be percutaneously 
implanted through a 0.5-mm-long incision on the zebrafish chest. Then the parylene-
encapsulated central strip was fixed along the abdomen by wrapping the side wings 
around the zebrafish like a belt (Fig. 3.7). The MEA head containing four working 
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electrodes (WE) was inserted into the epicardium while the reference electrode (RE) was 
anchored towards the fish tail.. The fish were allowed to recover in water free of Tricaine.  
 
Figure 3.9. Zebrafish with microelectrode membrane percutaneously implanted through 
an open-chest incision. The parylene C-based jacket was wrapped around the zebrafish 
and placed behind the pectoral fins.  
3.2.4.2 Recording Setup 
During each electrical signal acquisition, the sedated fish with the implant was 
placed on a damped sponge upside down. The FFC cable end was then inserted to a zero 
insertion force (ZIF) connector and connected to the recording circuitry. The whole setup 
was in a Faraday cage (Fig. 3.8).  
The signals were amplified by 10,000-fold (A-M Systems Inc. 1700 Differential 
Amplifier, Carlsborg, WA), and filtered with a bandpass filter between 0.1 and 500 Hz as 
well as  a notch filter of 60 Hz. The filtered signals were digitized at a sampling rate of 
1,000 Hz (National Instruments USB-6251 DAQ device, Austin TX, and LabVIEW 8.2). 
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Figure 3.10. Recording setup inside a faraday cage.  
3.2.4.3 The Equivalent Recording Circuit 
The simplified equivalent recording circuit is composed of the front-end 
metal/electrolyte interface model, the parasitic shunt capacitor and the back-end 
instrumentation amplifier with high input impedance. The conductive fish body was 
modeled as a resistor network. A particular recording electrode (A, B, C, or D) and the 
reference electrode were probed into two different points of this resistor network, one 
proximally to the heart and the other towards the tail. The shunt capacitors between the 
recording cables and decoupled to the fish body remained small and negligible as 
compared to the electrode interface impedances and instrumentation amplifier input 
impedance. The input impedance of the instrumentation amplifier stayed high as a 
parallel 1000 GOhm resistor with a 5 pF capacitor. The impedances of a working 
electrode with a diameter of 300 µm versus the reference electrode remained below 1 
MΩ at 100 Hz, ensuring a significant voltage drop across the instrumentation amplifier. 
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To minimize decoupling through the low-impedance path formed by fish body, the 
recording electrode should be positioned proximal to the source of cardiac conduction. 
 
Figure 3.11. Simplified equivalent recording circuit when recording from electrode A and 
the ground electrode.  
3.2.4.4 Data Processing of Recorded ECG Signal 
The signal-to-noise ratio (SNR) was enhanced by using both wavelet analysis and 
noise-reduction techniques. Initial ECG signals were recorded at 1,000 Hz. A wavelet 
transform was performed by breaking down the signals into 10 frequency segments 
ranging from 0Hz to the Nyquist frequency (i.e. 500 Hz). A pre-selected threshold value 
was applied to each individual frequency segment to suppress noise while retaining signal 
components. Table 3.1 shows the signal strength distribution of a representative ECG 
across each frequency segment. 
Table 3.1 Signal strength distribution of a representative ECG across each frequency 
segment. 
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High frequency signals were completely filtered out due to high level of noise; a 
small threshold value was set in the frequency range 7.8-62.5 Hz to remove the residual 
noise. Signals in the frequency range between 2.0 Hz and 7.8 Hz were kept intact to 
preserve T waves. The baseline drifting was eliminated by removing signals below 2 Hz. 
The processed ECG signals were reconstructed by inverse wavelet transform. The P 
waves, QRS complexes and T waves were retained, allowing significantly improved 
SNRs from approximately 2 dB for the raw data to 7.1 dB after processing. 
 
Figure 3.12 Data processing of recorded ECG signals.  
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3.2.5 Results and Discussion 
3.2.5.1 Reproducible ECG Signals Recorded via the Microelectrode Membrane 
The feasibility of the flexible microelectrode membrane in the freely swimming 
zebrafish has been demonstrated. The membrane is water-resistant. Despite the rapid 
movement of zebrafish during normal swimming, the head portion of the microelectrode 
membrane remained anchored in the epicardium, allowing for recording reproducible P 
wave, QRS complex and T waves on day 3 (Fig. 3.10). Currently, application of the 
surgical glue to the incision site of the fish promotes inflammatory responses, precluding 
further monitoring after day 3.  
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Figure 3.13. Zebrafish ECG signals acquired via an implanted MEA membrane over 3 
days.  Electrical signal acquisition revealed P wave, QRS complexes and T waves from 
the same animal on (a) Day 1, (b) Day 2, and (c) Day 3, respectively. 
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3.2.5.2 Cryo-Injury-Induced Aberrant Electrical Phenotypes in Zebrafish  
In response to cryo-injury, there was a significant change in ECG signals, 
revealing abnormal electrical repolarization in the cryo-injured heart. To investigate the 
injury-related aberrant electrical currents, ECG signals were recorded prior to cryo-injury 
and repeated on day 3 with the wearable microelectrode membrane percutaneously 
implanted. No significant drifts in ECG signals in terms of P waves and QRS complexes 
were observed. Injury currents, namely ST-depression, were observed and persisted on 
day 3 (Fig. 3.11). Unlike human ECGs, the T wave became more distinct in response to 
cryo-injury in zebrafish. Thus, the use of microelectrode membrane highlighted the 
feasibility of applying high-density microelectrodes to uncover small regions of 
myocardial ischemia with a minimally invasive approach.  
 
                                                         75 
Figure 3.14. ST depression in response to cryo-injury.  ECG signals acquired from the 
flexible microelectrode membrane percutaneously implanted in the same zebrafish (a) 
prior to, and (b) post cryo-injury on day 3. Myocardial ischemia remained on Day 3 as 
evidenced by ST depression. 
3.2.5.3 Multi-Channels to Acquire Injury Currents  
In 4-chamber human hearts, 12-lead surface ECG has routinely been used to 
identify the specific regions of myocardial injury [18]. In the 2-chamber zebrafish heart, 
4-lead surface ECG has made the detection of region-specific cryo-induced injury 
possible. The ECG signals recorded from all four working electrodes (A, B, C and D) 
show P waves, QRS complexes and T waves, reflecting atrial contraction, ventricular 
contraction and ventricular repolarization, respectively. Four working electrodes allowed 
for 4-lead ECG signal acquisition with improved spatial and temporal resolutions. 
Variations in the voltage amplitude among the four ECG signals reflected the different 
points of reference in electrode placement with respect to the cardiac conduction vector. 
As illustrated in Fig. 3.12, P-wave signals were more prominent in electrodes B, C and D 
than that of A because P wave reflects the electrical signals from the atrium and electrode 
A was connected to the atrium through the relative high-resistance myocardium. In the 
analysis of the ST segment, the placement of electrode D proximal to the injury region 
resulted in a notable ST depression. The electrodes distal to the injury region did not 
detect the injury current, and thus, did not exhibit ST-depression. Similar to the 12-lead 
ECG in humans, our 4-channel signal acquisition enabled detection of the specific 
regions where myocardial injury occurred for small animal models. In corollary, 
histology corroborated the region-specific injury currents. 
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Simultaneous 4-channel recording uncovered specific regions of injury currents 
with high spatial and temporal resolution. Surface ECG data from all four electrodes 
revealed synchronization in ECG intervals (Fig. 3.12). The histology of injured 
myocardium (Fig. 3.12(a)) corroborated the region-specific ECG signals. In this context, 
the SNR of our surface MEA is dependent on the placement of individual electrodes. In 
reference to detecting region-specific injury currents with high spatial resolution, the 
placement of an electrode proximal to the injury region results in detecting ST depression. 
The electrodes distal to the injury region will not exhibit ST-depression. This 
electrophysiological phenomenon is in line with that of human surface ECG. 
3.2.6 Conclusion 
The multi-channel microelectrode membrane detected the region-specific ECG 
signals with high spatial and temporal resolution in the cryo-injured zebrafish hearts. The 
wearable microelectrode membrane remained functional in aquatic conditions, achieving 
a technical advance for long-term signal acquisition.  
Engineering challenges have been addresse, including the use of high-density 
small-dimension microelectrodes to match the Young's modulus between the flexible 
membrane and the fish for long-term compatibility, and to obtain high SNR from the 
dynamic hearts. An optimal electrode dimension of 300 µm in diameter has been 
developed for optimal SNR with the current electrodes placement configuration.  
The microelectrode membrane also demonstrated the feasibility of long-term 
electrophysiological monitoring. The minimally invasive approach enables epicardial 
ECG acquisition over a prolonged period.  
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Figure 3.15. Simultaneous four-channel ECG recordings.  (a) Histological slides showing 
the evidence of cryo-injury. Simultaneous four-channel ECG signals were acquired. The 
implanted MEA membrane captured a region of myocardial injury otherwise undetected 
via the single electrode lead. (b)  4 channels were recorded simultaneously showing the 
synchronization in ECG intervals. (c) Electrode A revealed P, QRS, and T morphology 
without evidence of myocardial injury currents. Electrodes B, C and D (most obvious) 
uncovered a region of myocardium where cryo-injury induced ST depression. 
3.3 Wireless ECG Recording Backpack 
The previous microelectrode membrane is long-term wearable, but electrical 
connections need to be made for every measurement. Accordingly, animals need to be 
pharmacologically sedated. However, this approach influenced the intrinsic cardiac 
pacemaker cells resulting in atrial arrhythmia and heart rate reduction. In this section, a 
wireless ECG recording system to process the ECG signals sensed by the microelectrodes 
was designed and prototyped on a printed circuit board. The completed system includes 
modules for (i) wireless power supply through resonant inductive coupling, (ii) low-noise 
amplification and filtering of ECG signals, and (iii) amplitude-modulated infrared light 
emitting diode (IRLED) transmission of measured data.  
Through genetic fate mapping, Porrello et al. recently discovered the transient 
regenerating capacity of 1-day-old neonatal mice after birth, but this capacity is lost by 7 
days of age [19]. Thus, the wireless and continuous operation of the microelectrode 
membrane was demonstrated on the non-sedated 1-day-old neonatal mouse model of 
heart regeneration. 
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3.3.1 Design 
3.3.1.1 The wireless ECG Recording Microelectrodes: Linearly-Arranged Dry-
Contact Chest Microelectrodes 
In a 12-lead human ECG, six pads are linearly placed against the chest with 
conductive gel. By analogy to that, four recording microelectrodes are linearly arranged 
and placed on the neonatal mouse chest surface, but without any gel or adhesive. The 
titanium/gold microelectrodes are embedded in parylene-C membrane and selectively 
exposed at recording sites. An anchor is monolithically microfabricated adjacent to the 
recording microelectrodes for fixing the membrane against recording sites with surgical 
glue. The membranes are thermally annealed in a high-temperature vacuum oven to 
better match the chest curvature. The meandrous parylene C stripes were pre-coated with 
silicone to further secure the membrane to the chest surface with adequate 
accommodation for neonatal mouse size increase during heart regeneration.   
Dry-contact electrodes provide convenience and animal comfort for long-term 
continuous recording, but they are more prone to electrical noise and mechanical 
movement [20]. Here, strategies to enhance the signal-to-noise ratios (SNR) were 
developed at three different levels: sensor, system and algorithm. (i) At the sensor level, 
mechanical anchors and fixations were incorporated for positioning the electrodes on the 
anatomic regions. In response to the neonatal growth during heart generation, the 
expandability of the fixation was capable of adapting to the increase in size. (ii) At the 
system level, the post-processing circuitry was implemented with high input-impedance 
and low input-noise to compensate for the high interface impedance and noise level 
associated with the dry-contact electrodes. (iii) At the algorithm level, wavelet analysis 
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and noise-reduction techniques previously described further increased the SNR at the 
receiver side. 
3.3.1.2 The Wireless ECG Recording System: Amplification, Filtering and Optical 
Data Transmission 
The purpose of amplification and filtering is to measure the small-amplitude ECG 
differential signal amidst the large common-mode and differential noise. The signal 
processing and wireless communication circuitry prototyped on the printed circuit board 
includes two-stage amplification, band-pass filtering, inductive power transfer, and 
optical data transmission (Fig. 3.13).  
3.3.1.3 Solenoid Resonant Inductive Coupling 
Resonant inductive coupling instead of use of a battery is implemented to support 
the prolonged recording as described in Chapter 1. Typically, resonant inductive coupling 
is manifested in a planar configuration with the receiver implanted. For analysis of the 
size and swimming activity of zebrafish, a solenoid configuration is chosen.  
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Figure 3.16. Block diagram of the wireless ECG system. 
3.3.2 Implementation and Characterization 
3.3.2.1 The Wireless ECG Recording Microelectrodes: Microfabrication 
The microelectrode membrane was manufactured using micromachining 
techniques. Titanium/Gold electrodes sandwiched between two layers of parylene C were 
exposed to oxygen plasma etching at the recording sites and connecting pads. Four gold 
electrodes with a diameter of 200 μm were linearly arranged. The reference electrode was 
placed 5 mm away from the recording electrodes. There were four connecting pads 
assembled to a customized zero-insertion-force (ZIF) cable end by conductive epoxy and 
encapsulated by biocompatible silicone. The membrane measured ~10 μm in thickness 
and the weight was less than 0.5 mg. After an annealing process in the vacuum oven at 
200oC for two days, the membrane was curved to conform to the surface curvature of the 
neonate chests.  
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For long-term safety and comfort to the neonates, the dry-contact electrodes 
operated in the absence of conductive gel. The impedance at the skin-electrode interface 
was modeled as a resistor in series with a combination of parallel resistor-capacitor as 
previously discussed. At a frequency range of 2 Hz to 125 Hz, which is the interested 
frequency range of interest for ECG characteristics, the model was simplified to an 
interface capacitor.  
Low-power oxygen plasma was applied to roughen the microelectrode surface, 
allowing for an increase in the effective contact area and a decrease in the interface 
impedance while still maintaining a high spatial resolution. The introduction of a first-
stage amplifier with high input impedance rendered the microelectrode interface 
impedance negligible. As a result of the thin layer of micro-fabricated metal cables (0.2 
m in thickness) running in parallel and being connected to the input-stage amplifier, the 
shunt capacitance was also negligible 
The central portion of the microelectrode membrane was designed for securing to 
the abdomen along with the stretchable parylene C strips. The strips and sharp edges of 
the entire membrane were coated with a biocompatible silicone to match the Young’s 
modulus of the animal skin. A mechanical mismatch would result in cell and tissue 
damage and possibly infection. In addition, a meshed parylene C pad adjacent to the 
microelectrodes served as an anchor (Fig. 3.14(b)). The applied surgical glue permeated 
throughout the distributed holes, providing contact between the parylene C embedded 
microelectrodes and the animal chest. This unique design minimized electrical signal 
fluctuations due to respiration-induced mechanical noise, and reduced the interface 
impedance of dry-contact electrodes. 
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Figure 3.17. Fabricated device.  (a) The manufactured microelectrode membrane with 
meshed parylene-C pad and meandrous strips. (b) The Scanning Electron Microscope 
(SEM) photo with four gold microelectrodes and the meshed parylene-C pad. 
3.3.2.2 The Wireless ECG Recoding System: Printed Circuit Board 
The signal amplification and filtering were critical to address the small chest-
surface ECG signal strength (< 150 V) and frequency range (2-125 Hz). The signal 
processing circuitry required two-stage amplifiers and a band-pass filter prior to 
transmitting the signals to the data receiver. The ECG signals were first passed through a 
first-stage instrumental amplifier (INA333 from Texas Instrument) to provide high input 
impedance, and then to an operational amplifier (OPA333 from Texas Instrument) to 
allow for a band-pass filter and secondary amplification. Signals with frequency below 2 
Hz and above 125 Hz were filtered out by the high-pass and low-pass filters. The circuit 
communicated with the external data acquisition and process units via an Infrared Light 
Emitting Diode (IRLED). The circuit design highlighted the high-pass and low-pass 
filters in relation to the two-stage amplifiers (Fig. 3.15).  
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Figure 3.18. Circuit schematic of amplification, filtering and data transmission.  
 The frequency response up to 1 KHz was characterized (Fig. 3.16). Sinusoidal 
signals with frequencies ranging from 1Hz to 1KHz was applied to the input stage of the 
wireless ECG recording circuitry. The output was measured from the voltage on IRLED.   
 
Figure 3.19. Frequency response of the wireless ECG system  
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3.3.2.3 Inductive Power Transfer: Hand-wound Coil 
During operation of the system and the load, a DC voltage of 1.8 V or above and 
an average power of 300 W was required. In this case, the equivalent load was 
calculated to be 20 kΩ. A two-coil inductive link coupled in a solenoid configuration was 
designed to provide power continuously (Fig. 3.17). A miniaturized and high-quality-
factor receiver power coil was constructed by wrapping 30/48 Litz wires around a Ni/Zn 
ferrite core to establish high magnetic permeability and low electrical loss. The secondary 
coil had 8 turns, resulting in an outer diameter of 1.2 mm, an inner diameter of 0.7 mm, 
and a length of 4 mm. For the target frequency range, an inductance of 143 nH and a 
quality factor of 23.6 around 10 MHz were achieved.  
 
Figure 3.20. Inductive power transfer with hand-wound primary coil and secondary coil. 
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The overall power transfer efficiency was measured. A constant efficiency of 1.2% 
from 9-15 MHz was achieved (Fig. 3.18). In this context, the optimal operating frequency 
of 11.1 MHz was chosen. 
 
Figure 3.21. Overall power transfer efficiency of inductive coupling link. 
The microelectrode membrane was inserted into the zero-insertion-force (ZIF) 
connector on the board (Fig. 3.19). Single-channel wireless ECG signal recording was 
established between one of the four front electrodes and the reference electrode. 
 
Figure 3.22. Wireless ECG recording system including the insertable microelectrode 
membrane and printed circuit board prototype.  
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3.3.3 ECG Recording from Neonatal Mouse 
The wireless studies on the neonatal mice were performed in accordance with the 
Institutional Animal Care and Use Committees (IACUC) at Children Hospital Los 
Angeles, Los Angeles, CA, USA. The animal experiments were performed in compliance 
with the Guide for the Care and Use of Laboratory Animals of the National Institutes of 
Health. 
For wireless ECG recording, neonatal mice aged between one to seven days old 
were positioned on a baseplate without sedation. The wireless ECG recording system was 
first gently fixed on the abdomen by thin strips of medical tape, followed by adhering the 
microelectrode membrane to the chest. Surgical glue (Dermabond AdvancedTM) was 
applied to the anchoring meshed pad and permeated through the holes. The mouse lying 
on baseplate was then placed inside the power-transmitting coil with a diameter of 2.8 cm. 
When the power was activated to the transmitting coil, real-time ECG signals were 
acquired (Fig. 3.20).  
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Figure 3.23. Wireless ECG recording from neonatal mouse. (a) The experiment setup of 
the wireless ECG recording. The neonatal mouse was positioned on the baseplate in 
enclosed by the transmitting coil. (b) The mouse with device on a baseplate (c) after 
insertion into the transmitter coil. 
3.3.4 Results and Discussion 
Reproducible trials on neonatal mice were performed to reveal distinct ECG 
signals in the presence and absence of pharmacological sedation. A comparison in ECG 
signals between the non-sedated and sedated conditions highlighted the distinct heart 
rates and ECG repolarization patterns (Fig. 3.21(a)). A reduction in the heart rates by 50% 
was noted in the presence of sedation (80 µg/gr body weight Ketamine/xylazine). With 
the mechanical interference during recording and the signal attenuation during 
transmission, the P waves, QRS complexes and T waves remained distinct despite a 
reduction in SNR without sedation (Fig. 3.21(b)).  
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Figure 3.24. (a) A comparison of ECG signals between the sedated and non-sedated 
conditions. Heart rates are ~300 rpm and ~600 rpm for the sedated and non-sedated mice, 
respectively. (b) A representative signal-processed ECG tracing revealing the P wave, 
QRS complex and T wave. 
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3.3.5 Conclusion 
For the first time, ECG signals have been continuously obtained from a one-day-
old mouse model of heart regeneration, in the absence of pharmacological interference, 
with the intrinsic heart rates. The wearable and wireless-operated microelectrode 
membrane has been designed and demonstrated to enable continuous monitoring of 
cardiac rhythms for prolonged intervals. The membrane’s conformity to the non-planar 
recording surface and the long-term expandability to the increase in size of the animals 
provided numerous translational implications for long-term in-situ detection of aberrant 
electrical activities for cardiac and neurological drug screening, disease and trauma 
modeling, and toxicity studies. 
3.4 Flexible ECG Printed Circuit Membrane 
In this section, the parylene C-based flexible printed circuit membrane was 
developed as a flexible and miniaturized counterpart of the printed circuit board (PCB). 
The strategies of circuit design and component assembly were formulated. The same 
wireless ECG recording system was implemented on the parylene C-based printed circuit 
membrane with integrated circuit bare dies and discrete components assembled. The 
sensing electrodes were monolithically fabricated with printed circuit membrane. The 
size and weight have been tremendously reduced with the circuit presenting the same 
functionality and performance 
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3.4.1 Design 
3.4.1.1 Size and Weight Constraints  
 Zebrafish measure 3-4 cm in length. A wearable parylene C jacket has been 
previously demonstrated which provided a reference size for the implant design. Ideally, 
all the components should be within the domain of the jacket which is roughly 2 mm in 
width and 15 mm in length.  
 A zebrafish load test was carried out to identify the upper-limit weight that an 
adult zebrafish can carry during normal swimming. 50 mg was found to be a maximal 
comfortable load weight.  
The wireless ECG recording circuit was previously prototyped on the printed 
circuit board with functional modules of signal processing, wireless data transmission and 
wireless power transfer. To substantially reduce the size and weight, two strategies were 
adopted: (i) The rigid printed circuit board was replaced by a thin-film parylene-C printed 
circuit membrane with embedded thin-film metal routings. (ii) All the chips were 
replaced by bare dies that are the same chips without packages. In addition, small 
packages of the discrete components were chosen.  
 Table 3.2 summarizes all the components with individual length, width, height 
and weight.  Components add up to 25 mg. Taking into consideration the weight of the 
printed circuit membrane and necessary packaging coatings for underwater functioning, 
the total weight will probably be close to the weight upper limit.  
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Table 3.2. Component list with length, width, height and weight. 
 
It is worth mentioning that the original hand-wound power receiver coil was 
replaced by an off-the-shelf wire-wound unshielded coil (Fig. 3.22). According to the 
datasheet, the coil has an inductance of 1 H and a quality factor of 30 minimum at 7.96 
MHz, and is therefore qualified for the inductive power transmission. Compared to 
previous hand-wound coil, this one has similar performance, but its package provides 
convenience for integration.  
 
Figure 3.25. Off-the-shelf wirewound unshielded coil for general use in inductive 
coupling. 
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3.4.1.2 The Design of the Parylene C-Based Printed Circuit Membrane 
The printed circuit membrane is constructed of a patterned thin metal layer 
embedded in between two parylene C layers and selectively exposed where electrical 
connections need to be made. The metal layer pattern is equivalent to the interconnecting 
layout design of the printed circuit board (PCB). In the first parylene C printed circuit 
membrane layout (Fig. 3.23), the four modules of signal sensing, signal processing, 
wireless data transmission and wireless power transfer are linearly arranged from left to 
right. The thin strip measures 2 mm in width. The head with signal sensing 
microelectrodes are percutaneously implanted into the heart as described previously. The 
Vcc and GND are distributed on the two sides of the layout.  
 
Figure 3.26. Circuit routing with all the necessary interconnections and pads. 
The first layout design includes all the necessary interconnections and pads. 
While in the prototyping stage, additional debugging routings and pads are usually added 
to facilitate debugging. For the parylene printed circuit membrane, debugging pads and 
routings are even more necessary for two reasons: (i). Metal layers are embedded under 
the top parylene C layer and exposed pads are covered after being connected with 
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components. Thus probing cannot access to all the nets. (ii). The circuit membrane with 
components assembled is very delicate and tends to not take a lot of mechanical 
stretching during probing. Debugging pads and routings can take up extra space, which is 
not acceptable with the extreme size constraint. Therefore, tear-off debugging pads are 
added to the original circuit design (Fig. 3.24). After the debugging, those pads can be 
detached from the central circuit membrane. The schematic diagram of the print circuit 
membrane with all the components assembled is shown (Fig. 3.25).  
 
Figure 3.27. Printed circuit membrane design with debugging routings and tear-off 
debugging pads highlighted in red. 
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Figure 3.28. Schematic diagram of the print circuit membrane with all the components 
assembled. 
Parylene does not withstand high temperature soldering. All the connections need 
to be made manually by conductive epoxy. The connections made through conductive 
epoxy, once fully cured, cannot be changed or removed. Therefore, in order to increase 
the overall yield, the one-piece circuit design is divided into three pieces (Fig. 3.26). 
Every individual sub-circuit has its own debugging routings and pads. These are called 
primary debugging pads (Fig. 3.27). Working sub-circuits can be combined through the 
connecting pads. The combined circuit can be debugged further more with secondary 
debugging pads and so on. There are non-conductive parylene pads on both sides 
designed to facilitate handling and alignment during combining.  
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Figure 3.29. Comparison of one-piece circuit and three pieces of sub-circuits. 
 
Figure 3.30. Design of three-level debugging pads, the connecting pads and the alignment 
assisting pads. 
3.4.1.3 The Assembly Techniques of Discrete Components and IC Bare Dies 
As mentioned before, parylene C doesn’t stand up to high-temperature soldering. 
Wire bonding is not suitable either because the thin-metal layer on top of thin parylene 
film doesn’t withstand the pressure during bonding. Therefore, conductive epoxy is used 
for connecting all the components.  
 For the discrete components with two pads on the sides, the assembly procedure is 
straightforward. Apply small drops of conductive epoxy right on top of the exposed metal 
pads on printed circuit membrane, align components with the pads, place them on top and 
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gently press down. To enhance the yield, the pads of the discrete components should be 
refreshed by heating with a soldering iron.  
 For the IC bare dies, a combined assembly technique is used (Fig. 3.28). The pads 
on bare dies are measured 75 m by 75 m. Through holes are made on printed circuit 
membrane in accordance with the dimensions and arrangements of the bare die pads. 
Regarding the through holes, they should have larger openings on the top parylene than 
that on the metal and bottom parylene. To make the connections, the bare die is first 
placed underneath the printed circuit membrane. There are non-conductive through-holes 
around the connecting through-holes to mechanically hold the bare dies with the 
membrane. After aligning the connecting through-holes with the pads on bare die, 
silicone is first applied around the non-conductive through holes. After curing the 
silicone, the assembly of the membrane and bare die is fixed onto a substrate printed 
circuit board with water-soluble wax. Electrical connections can be made directly by 
applying conductive epoxy and connecting the ring-like embedded metal with bare die 
pads. However, the bare dies utilized have aluminum pads and there generally exists a 
thin-layer of oxide. To build a reliable electrical connection, the pads are first wire 
bonded to peripheral pads on the substrate printed circuit board. The gold bonding wires 
are electrically connected to the pads. Because the gold doesn’t get oxidized, conductive 
epoxy is applied around the gold bonding wire to connect the bonding wire with the 
embedded metal in the membrane. With the conductive epoxy fully cured, the bonding 
wire not buried inside the conductive epoxy drop can be cut off. Thus, this assembly 
procedure provides both electrical and mechanical reliability.  
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Figure 3.31. Cross-sectional view of the bare die assemble. 
 
Figure 3.32. 3D drawing of the assembled bare die and discrete resistor. 
3.4.1.4 The Assembly and Debugging Procedure 
 The step-by-step assembly and debugging procedure is illustrated here in detail.  
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(1) The printed circuit membrane and the sensing microelectrodes are 
microfabricated in the same process. The process is same as the previously 
described parylene-metal-parylene sandwich structure with metal exposed at 
where electrical connections need to be made.  
 
Figure 3.33. Printed circuit membranes of three sub-circuits. 
(2) The discrete components are assembled onto sub-circuits. The connections are 
checked by probing.  
 
Figure 3.34. Three sub-circuits with discrete components assembled. 
 The sub-circuit C has an inductor and a capacitor connected in parallel. The 
quality factor of the resonator is tested to ensure low contact resistances between the 
resistor and capacitor.  
(3) The bare dies are assembled onto sub-circuit A and sub-circuit B respectively. 
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Figure 3.35. Sub-circuit A and sub-circuit B with bare dies assembled. 
(4) Assembled sub-circuit A and sub-circuit B are connected to debugging printed 
circuit boards with the primary debugging pads. The functionalities of the two 
sub-circuits are tested with the assistance of the external circuitry. Then the 
tear-off primary debugging pads can be removed from the working sub-
circuits.  
 
Figure 3.36. Sub-circuit A and sub-circuit B before and after removing primary 
debugging pads. 
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(5) After debugging and removing the debugging pads of sub-circuit A and sub-
circuit B, they are connected together.  
(6) Assembled sub-circuit A+B is connected to a debugging printed circuit board 
with the secondary debugging pads. The functionality of the sub-circuit A+B 
is tested with the assistance of the external circuitry. The tear-off secondary 
debugging pads can be removed from the working sub-circuits.  
 
Figure 3.37. Sub-circuit A+B before and after secondary debugging pads are removed. 
(7) The rest of the discrete components are assembled on sub-circuit C. The 
functionalities of sub-circuit C is tested with the assistance of the external 
circuitry. The tear-off primary debugging pads can be removed from the 
working sub-circuit C.  
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Figure 3.38. Sub-circuit C with all the discrete components assembled.  
(8) After debugging and detaching the debugging pads from sub-circuit C, sub-
circuit A+B and sub-circuit C are connected together. The functionality of the 
sub-circuit A+B+C is tested with the assistance of the external circuitry. The 
tear-off tertiary debugging pads can be removed from the working circuit. 
Finally, the align assisting pads are finally removed as well.  
 
 
Figure 3.39. Final look of the complete wireless ECG system with sensing electrodes and 
all the electronic modules.  
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3.4.2 Fabrication and Characterization 
3.4.2.1 The Microfabrication and Assembly of Three Sub-circuits 
  The microelectrodes and the printed circuit membranes were 
monolithically microfabricated in the same parylene-metal-parylene process. Before 
assembling the discrete components onto the sub-circuit membranes, the membranes 
were cleaned by a low-power oxygen plasma etching. Then discrete components and 
bared dies were assembled and checked following the order described in the design 
section (Fig. 3.37).  
 
Figure 3.40. Microfabrication and assembly flow of the three sub-circuits. 
3.4.2.2 The Characterization of Sub-circuits 
The previous hand-wound power receiver coil has been replaced by off-the-shelf 
wire-wound unshielded coil. Therefore, the inductive coupling link was re-characterized 
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(Fig. 3.38). At an operation frequency of 10.8 MHz, the link provided power of 670 W 
with a DC supply of 2.6 V, satisfying the power and voltage requirements of the signal 
processing and data transmission electronics.  
 
Figure 3.41. Assembled sub-circuit C and the power transfer efficiency testing.  
Sub-circuit A and sub-circuit B were connected to debugging printed circuit 
boards with primary debugging pads. They were tested with external assisting circuitry.  
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Figure 3.42. Sub-circuit A and sub-circuit B connected to debugging printed circuit 
boards with primary debugging pads.  
Before removing the primary debugging pads and taking the sub-circuits from the 
debugging printed circuit boards, debugging printed circuit boards, with sub-circuit A 
and sub-circuit B, respectively, were connected using bread board. The recorded ECG 
signals from a bench-top ECG simulator were shown on the oscilloscope.  
 
Figure 3.43. Sub-circuit A and sub-circuit B connected through bread board for testing.  
After removing the primary debugging pads on sub-circuit A and sub-circuit B, 
these two sub-circuits were removed from the debugging printed circuit boards and 
connected using conductive epoxy.  
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Figure 3.44. Assembled sub-circuit A+B. 
After sub-circuit A+B was debugged, sub-circuit A+B was connected to sub-
circuit C to form the sub-circuit A+B+C.  
3.4.2.3 The Characterization of the Final Device 
Sub-circuit A+B+C was connected onto the debugging printed circuit board with 
tertiary debugging pads. The inputs were from the bench-top ECG simulator. ECG 
signals were repeatedly recorded and the P waves, QRS complexes and T waves were all 
detected.  
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Figure 3.45. Testing platform of the wireless ECG recording system prototyped on 
parylene printed circuit membrane.  
 
Figure 3.46. Recorded ECG signals from simulator on bench top 
The final device measures 2 mm in width, about 16 mm in length and weighs 
about 35 mg. Compared to its counterpart prototyped on printed circuit board, the final 
device is flexible, light and compact.  
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Figure 3.47. Comparison of the ECG wireless recording system prototyped on printed 
circuit board and on printed circuit membrane.  
3.4.3 Discussion and Conclusion 
The parylene C-based printed circuit membrane has achieved flexible, light-
weight and compact integration of the wireless ECG recording system. The design of 
sub-circuits not only enhanced the overall yield, but also provided the possibility of 3D 
integration. 
As in the zebrafish application, a 3D integration is needed. Based on our load test 
(Fig. 3.45), when the implant mockup aligned with the center of gravity of the zebrafish, 
the fish could carry the heaviest load (50 mg). This provided a reference for the special 
integration of the implant, which preferably spans 1.5-2.5 mm in width and 8.5 mm in 
length. Therefore, a design with three sub-circuits stacked and connected is superior to 
the current long strip with three sub-circuits lined up and connected.   
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Figure 3.48. Loading area of zebrafish.  
In addition, the second major challenge for zebrafish ECG monitoring is the long-
term underwater packaging. A combination of parylene C, silicone and other polymers 
can potentially maintain the flexibility of the packaging, but may not be adequate for 
two-month underwater application. So a novel packing technique that can be long-term 
water resistant and mechanically match the Young’s modulus of fish skin is needed.  
3.5 Conclusion  
The work in this chapter developed a long-term in vivo monitoring system. In the 
beginning, a passive microelectrode sensor carried by a long-term parylene C-based 
membrane was designed and fabricated. Multiple microelectrodes were percutaneously 
implanted onto the zebrafish heart surface Region-specific aberrant cardiac currents of 
injured and regenerating hearts were recorded simultaneously in a prolonged interval, 
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which proved the feasibility and significance of applying ECG monitoring during heart 
regeneration. To enable continuous recording from non-sedated and non-restricted 
animals, the passive microelectrode sensor was demonstrated to operate wirelessly with a 
wireless ECG recording system prototyped on printed circuit board. ECG signals from 
non-sedated one-day-old neonatal mouse were wirelessly recorded. To further achieve 
zebrafish wireless ECG recording, a novel integration platform was developed to 
miniaturize the wireless ECG system. Parylene C-based printed circuit membranes 
provided a flexible, light weight and compact substrate for electrically interconnecting 
and mechanically carrying all the electronic parts.  
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Chapter 4 Conclusion 
The development of innovative microimplants for in vivo sensing usually starts 
with a biomedical or clinical challenge identified in clinical practice. A crucial step 
afterwards is how to design the implant by breaking down the sensing requirements into 
the function modules of hardware implementation as discussed in Chapter 1. After 
designing, implementing and characterizing each individual function module, the 
modules need to be put together and configured collectively to build up a system. Then, 
the system is tested on the bench top, with animals, and then later in clinical trials.  
Despite the advances in diagnosis and therapy, atherosclerotic cardiovascular 
diseases still remain the leading causes of morbidity and mortality in developed countries. 
Predicting metabolically active atherosclerotic plaques has remained an unmet clinical 
need. The catheter-based impedance sensor with an inflatable balloon was developed to 
characterize the inflammatory states of high-risk unstable atherosclerotic plaques. The 
novel quasi-concentric microelectrode impedance sensor detected distinct 
electrochemical impedance spectroscopy (EIS) measurements for unstable atherosclerotic 
plaques that harbored active lipids and inflammatory cells. The inflatable balloon 
provided a well-controlled in vivo contact securing a proper contact with the plaques 
under test.  
This study presents the use of a robust and innovative balloon catheter-based 
concentric EIS sensor for the detection of endoluminal electrochemical properties. The 
demonstrations with explants from fat-fed NZW rabbit aortas and carotid arteries, 
respectively, further corroborated the link between endoluminal properties and lipid-rich 
                                                         114 
plaques. While EIS is a sensitive approach to assess lipid-rich plaques, its specificity 
would be strengthened by integrating with ultrasound (IVUS).  While the high-frequency 
IVUS (20-60 MHz) will enable us to resolve spatial resolution from 400 µm to 30 µm, 
the concentric bipolar microelectrode sensor will detect distinct endoluminal impedance 
spectra in the presence of high-fat versus normal diets [1, 2]. An integrated IUVS-EIS 
strategy will likely enhance the possibility of co-registration of ultrasound with the EIS 
measurements, and will detect an increase in EIS magnitude in non-obstructive plaques 
that occupy less than 20% of the luminal diameter, but harbor oxLDL and foam cells. 
Hence, integrating EIS with IVUS would improve both the sensitivity and specificity in 
identifying the metabolically active, but non-obstructive plaques [2].  
On the other hand, a flexible microelectrode membrane was developed to monitor 
zebrafish electrocardiogram (ECG) during heart regeneration. In humans, myocardial 
infarction results in the irreversible loss of cardiomyocytes. Zebrafish hearts fully 
regenerate after resection or cryo-injury, without either scarring or arrhythmias. To study 
the cardiac regeneration, a passive long-term wearable membrane with multiple 
microelectrodes was first demonstrated to measure region-specific ECG signals from 
zebrafish in a prolonged period. Following that, the wireless and continuous operation of 
the microelectrode membrane was presented in order to allow recording from non-
sedated animal models. Further miniaturization has even explored to achieve a flexible, 
light-weight and compact wireless ECG recording system prototyped on a parylene 
printed circuit membrane.  
The wearable MEA membranes provide electrophysiological insights into the 
aberrant conduction phenotypes of regenerating tissues, otherwise difficult with the 
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micro-needle approach. The integration-enabled design paves the way for long-term 
water-proof electrical signal acquisition via wireless technology. As such, the polymer-
based multi-channel MEA membranes hold promise for translational medicine, from 
assessing ECG in cardiac repair to monitoring electroencephalography (EEG) in seizure 
or brain injury.  
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